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ABSTRACT
The domestic chicken is an attractive, but underutilized, animal model for studies
of adipose tissue biology, metabolism and obesity: 1.) like humans, chickens rely on liver
rather than adipose tissue for the majority of de novo lipogenesis; 2.) quantitative trait
loci (QTLs) linked to fatness in chickens contain genes implicated in human
susceptibility to obesity and diabetes; 3.) chickens are naturally hyperglycemic and
insulin resistant; and 4.) a broad selection of genetic models exhibiting a range of fatness
are available. To date, however, little is known about regulation of adipose metabolism in
this model organism.

Affymetrix arrays were used to profile gene expression in abdominal adipose
tissue from broiler chickens fed ad libitum or fasted for five hours. Quantitative real time
polymerase chain reaction (QPCR) was used to validate microarray results for select
genes. A total of 1780 genes were differentially expressed in fasted vs. ad libitum fed
(p<0.05) tissue after correction for multiple testing. Gene Ontology and pathway analyses,
combined with Western blot validation, indicated significant effects on a broad selection
of pathways related to metabolism, stress signaling and adipogenesis. In particular,
fasting upregulated rate-limiting genes in both the mitochondrial and peroxisomal
pathways of beta-oxidation. Enhanced fatty acid oxidation in white adipose tissue was
further suggested by a significant increase in tissue content of the ketone betahydroxybutyrate. Expression profiles suggested that, despite the relatively brief duration
of feed withdrawal, fasting suppressed adipogenesis; expression of key genes in multiple
steps of adipogenesis, including lineage commitment from mesenchymal stem cells, were
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significantly down-regulated in fasted vs. fed adipose tissue. Interestingly, fasting
increased expression of several inflammatory adipokines and components of the toll-like
receptor 4 signaling pathway. A second study with Affymetrix microarrays of Fayoumi,
Leghorn and broiler adipose tissue revealed that genetic leanness shared molecular
signatures with the effects of fasting. In supervised clustering analysis, fasted broiler
chickens clustered with lean Fayoumi and Leghorn lines rather than with the fed broiler
group, suggesting that fasting manipulated expression profiles to resemble those of the
lean phenotype.
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CHAPTER I
LITERATURE REVIEW

Introduction and Objectives
The broiler industry has experienced decades of rapid expansion due to
population growth and the public’s preference for white chicken meat, creating a ~$26
billion broiler market in 2012 in the United States [1]. Broiler production now exceeds
that of both beef and pork, and broilers are the most efficient of the major food animals.
Intensive genetic selection for rapid growth has allowed the broiler industry to keep up
with the demand. However, it has also resulted in undesirable traits, including an
increasing fat content. Carcass fat in broilers at market age accounts for 10-15% of the
total carcass weights [2]. Excess fat is an economic loss to the broiler industry because it
wastes feed by its conversion to adipose rather than lean tissue and because of costs
incurred from the need to dispose of fat after processing. Excess fat may also contribute
to the development of detrimental traits arising from genetic selection for rapid growth,
such as reduced fertility and immunocompetence, both of which are seen in obese
humans [3]. The broiler industry requires new strategies to reduce the fatness in broilers,
which would economically benefit producers and likely improve health and welfare of
chickens. Such strategies require the knowledge of adipose tissue metabolism and
biology, which is still limited in chicken.
The overall objective of this dissertation was to identify the mechanisms that
regulate fat deposition in domestic chickens using an approach that couples
comprehensive transcriptomic and metabolomic methods with system and cellular
physiology. The objective of study 1 was to characterize the effects of energy restriction
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and insulin on adipose tissue in broiler chickens. The objective of study 2 was to identify
functional gene and metabolite classes differentially expressed in adipose tissue of lean
(Fayoumi and Leghorn) and broiler chickens. The objective of study 3 was to identify the
similarity between lean chickens and the fasted broilers. The data from study 1 & 2 were
then integrated together using statistical model to identify the similarity between fasted
broilers and lean chickens.
The findings of this work will provide comprehensive information to identify
potential new targets for genetic selection or management strategies to reduce fat
accumulation in commercial broilers and to further develop chicken as a model organism
for studies of human obesity.

Domestic Chickens
Domestic chickens originated from their wild ancestor, red jungle fowl, about
8,000 years ago in Southeast Asia according to the archaeological evidence [4]. Chickens
exhibited genetic adaptation to a new environment morphologically, physiologically and
behaviorally during long term domestication [5]. In recent decades, chickens have been
subjected to human-driven selection mainly for food purposes by laying eggs or
providing meat, leading to remarkable phenotypic changes.
Selection driven by the poultry meat and egg industries resulted in a decrease in
the total number of chicken breeds and produced the breeds that currently dominate the
world’s poultry industry, especially between 1930 to 1950 [6]. Layers were selected by
simultaneous improvement of multiple traits, including the age at sexual maturity,
livability, egg number, shell strength, egg size, and egg weight [7]. Therefore, the
dominant egg-laying lines used commercially today, including White Leghorns, Golden
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Comets and Rhode Island Red, are characterized by quick maturity, low mortality, small
body size, high production of saleable eggs, low feed cost per egg production and
optimal egg quality. For example, feed conversion of layers has improved from 2.95 to
2.01 g feed per gram egg, from 1960 to 2001[8], and egg production has increased from
176 to 309 eggs per hen per year from 1925 to 1998.
Today’s meat type chickens mostly refer to broilers. Modern broilers with
superior meat production performance are based heavily on a crossbred of White Cornish,
New Hampshire and White Plymouth Rock. They exhibit features of fast growth,
efficient feed conversion and high yield of breast muscle [2]. Their parental lines, White
Cornish, New Hampshire and White Plymouth Rock, are dual-purpose breeds for both
egg and meat, and have inferior meat production but better egg production compared to
broilers.
The broiler and egg industry has established an efficient and sustainable industry
by using genetic improvement. The U.S. Department of Agriculture (USDA) has forecast
that 37.3 billion pounds of broiler meat with the value of $27.7 billion will be produced
in 2013 according to the USDA Livestock, Dairy and Poultry Outlook. Likewise. total
egg production will be about 7.5 billion pounds.
Genetic Selection
Modern commercial broiler breeding was initially developed in the United States
as a result of selection for rapid growth. In 1945, the American grocer A&P (Atlantic &
Pacific Tea Company) organized the national “Chicken of Tomorrow” contests to
encourage meat-type poultry breeders to develop a more efficient broiler [9]. The genetic
selection criteria were initially based on the weight and growth rate of birds, which were
stable and heritable traits and helped improve broiler breeder performance. As feed costs
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rose, the industry switched the selection criteria to feed efficiency, which helped to
produce chicks cost effectively.

Genetic selection has greatly improved chicken

production over the last 50 years and provided high quality dietary protein to humans.
The market age of today’s broiler is about 6 weeks compared to 12 weeks in 1950s [10].
It only needs 3.4 kg of feed in less than 40 days to produce a 2.0 kg broiler today, in
contrast to 7.2 kg of feed in 95 days to produce a 1.3 kg broiler before genetic selection
[3].
However, intensive genetic selection for rapid growth inadvertently selected for
increased carcass fat. Carcass fat in broilers at market age accounts for 10-15% of the
total carcass weight and deposits at a rate of up to six grams fat/kg body wt/day between
42 and 49 days of age [2, 11, 12]. This is probably because abdominal fat is
proportionately largest when body weight and growth rate are the critical traits selected,
since it has a higher heritability than skeleton. Also, the broiler tends to overconsume
feed, which is another reason for fat deposition in broiler chickens. Excess fat is an
economic loss to boiler industry by reducing the conversion of feed to meat, and the
disposal of fat leads to additional economic loss. Excess fat may also contribute to the
development of other detrimental traits, such as reduced reproductivity and
immunocompetence, which consequently affect growth and yield of meat [3].
To solve these problems, broiler breeder management programs developed feed
restriction methods, i.e., skip-a-day feeding regimen, to manage broiler breeders [13]. In
this practice, from 21 to 140 days, broiler breeders are fed two’s days’ worth of feed on
one day and no feed on the next day. In total, the same amount of feed is provided but the
feed is rapidly consumed, producing a window of fasting. This has proven to be an
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effective approach to control excess fat deposition in broiler chickens by altering hepatic
lipogenic gene expression and abdominal fat content [14-17]. However, feed restriction is
not the ultimate solution, because it is associated with reduced body weight and meat
production, hunger stress and impaired welfare [18]. Skip-a-day program is practiced
widely in the USA, but there are some restrictions and regulations already in place to
limit the application of this program. In particular, its use is banned in some European
countries, e.g., in the UK. The US is expected to face the challenge to address these
welfare issues in the coming years.
Therefore, a successful strategy that can reduce fat deposition without
compromising lean meat growth is required. Unlike humans, increasing energy
expenditure by increasing exercise is not an option for chickens. A successful strategy,
either by genetic selection or by diet and nutrient management, would alter energy
portioning, preferentially deposit into lean tissue or increase utilization of fat for energy.
The fact that there are both naturally leaner and fattier lines of chickens among the
spectrum of common breeds illustrate that there are mechanisms that affect fatness in
chickens. However, little is known about these mechanisms. Thus, it would be of
particular interest to understand the cellular and molecular pathways leading to fat loss by
feed restriction or nutrient deprivation, and to further manipulate the genes associated
with adiposity in broiler chickens.
Several genetic lines of fat and lean chickens have been developed through
different phenotypic selection strategies. These lines have been used to study the
relationship between lipid metabolism, fatness and rapid growth. The lines selected by
Siegel for 8-week high and low body weight are representative models to study the
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correlated traits associated with rapid growth. High body weight chickens showed
increased feed efficiency, feed consumption, increased carcass fat, increased muscle size
and number, egg size, but decreased plasma growth hormone, immunocompetence and
egg production [3]. Lean broiler chickens with reduced abdominal fat and body lipids
were also obtained through selection on higher feed efficiency (feed consumed/weight
gain), which confirmed high negative correlation between feed efficiency and fatness
[19].
Genetic lines have also been selected for plasma levels of very-low-density
lipoprotein (VLDL). The high VLDL line of chickens had 38% difference in total lipids
and 49% more abdominal fat weight, but there were no differences in body weight, food
intake, hepatic lipogenesis, and lipoprotein lipase (LPL) activity in the high VLDL line
compared to the low VLDL line [20]. Similarly, selection for low plasma glucose level
resulted in fat chickens [21]. These studies clearly demonstrated the relationship between
lipid and carbohydrate metabolism and fatness.
Direct selection specifically on low abdominal fat content effectively resulted in
leaner broiler chickens [22]. The fat line chickens that resulted from this selection criteria
had four times more abdominal fat and 72% more lipids than lean line chickens, but no
difference in body weight or food intake [22]. Hepatic lipogenesis, VLDL secretion, SCD
(Δ9-Desaturase) activity, and adipocyte size and number were also higher in fat line
chickens [23, 24]. Collectively, fat line chickens produced through various genetic
selection criteria showed common features, including high plasma levels of VLDL, low
plasma levels of glucose, high hepatic lipogenesis and adipocyte size and number. These
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results reflected importance of hepatic lipogenesis and glucose consumption in fat
accumulation.

Adipose Tissue Biology
White adipose tissue & brown adipose tissue
In mammals, there are two major types of adipose tissue: white adipose tissue and
brown adipose tissue. White adipose tissue, the most common type of adipose tissue, is
characterized by large lipid droplets in which triglyceride are stored. Brown adipose
tissue is “brown” because of a high density of mitochondria. The hallmark of brown
adipose tissue is expression of mitochondrial uncoupling protein-1 (UCP-1), which
uncouples proton transfer in mitochondria from Adenosine-5'-triphosphate (ATP)
generation, and the dissipation of energy as heat rather than its storage in ATP. White
adipose tissue can be further classified as subcutaneous and visceral fat, according to the
location in the body [25]. Subcutaneous fat is located beneath the skin and visceral fat is
adipose tissue that lies around the central organs. The predominant site of adipose
deposition in chickens is abdominal fat and, to a less extent, subcutaneous fat and
intramuscular fat. Chickens have relatively low intramuscular fat compared to other
agricultural animals [26], and no brown adipose tissue, which differs from rodents
(present throughout life) and humans (present at birth, reduced in adults) [27].
Adipogenesis
White adipose tissue is composed of mature adipocytes and cells of the stromal
vascular fraction, including preadipocytes, mesenchymal stem cells (MSC), endothelial
cells and immune cells, such as T cells and macrophages [28]. Adipocytes arise from
mesenchymal stem cells (MSC), a multipotent stem cell that has the potential to
differentiate into adipocytes and other tissues of mesenchymal origin. This is a two-step
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process: preadipocytes are generated from MSC by lineage commitment and differentiate
into mature adipocytes through early differentiation and terminal differentiation [29].
This process is orchestrated by a transcriptional cascade involving the peroxisome
proliferator-activated receptor gamma (PPARγ),CCAAT-enhancer-binding protein alpha
(C/EBPα) and sterol regulatory element binding protein-1c (SREBP1) [30-32]. PPARγ is
a member of the nuclear receptor superfamily and is activated by a variety of fatty acids
and their derivatives, such as prostaglandins. PPARγ participates in adipogenesis through
binding as obligate heterodimers with retinoic X receptor (RXR). C/EBPα is expressed
late in adipogenesis and is a key regulator of adipocyte differentiation by regulating
expression of adipogenic genes. SREBP1 is the transcription factor that is expressed in
the early stage of adipogenesis and activates PPARγ by secreting lipid molecules that
bind directly to PPARγ [33, 34].
The molecular steps of adipogenesis are comparable between chickens and
humans. Retroviral transfection of C/EBPα, PPARγ and SREBP-1 into chicken embryo
fibroblasts could induce embryo fibroblasts differentiation into adipocyte-like cells
associated with lipid droplets accumulation and increased A-FABP [32]. A recent study
pointed out that fatty acid is essential to induce adipocytes differentiation and identified
regulatory factors that affect glycerol-3-phosphate dehydrogenase (GPDH) activity,
intracellular triglyceride accumulation and adipogenesis in chicken, including expression
of PPARγ and fatty acid-binding protein (aP2) [35].
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Adipose Tissue Metabolism
Adipose tissue is the major site for energy storage in the form of triglyceride. A
triglyceride molecule consists of three fatty acids esterified to a glycerol backbone.
Glycerol is produced from glucose through glycolysis and glyceroneogenesis. In
mammals, fatty acids can come from diet or be synthesized from glucose in lipogenic
tissue by catalyzed by fatty acid synthase. Dietary fatty acids are absorbed by enterocytes,
packaged with cholesterol, lipoproteins and other lipids into chylomicrons, and
transported into circulation. Blood-borne chylomicrons are rapidly disassembled, utilized
or stored in adipose tissue. Lipids synthesized in the liver are packaged into VLDLs and
released into the blood directly. TAG-rich VLDL reaching the surface of adipose tissue
vascular are targets of lipoprotein lipase (LPL) and release fatty acids, which are taken up
by adipocytes.

In chickens, the contribution of portomicrons (similar to chylomicrons in
mammals) from dietary fats to triglyceride is low, since there is about 5% of dietary
lipids in regular feed [36]. Triglyceride (TAG) deposits in chicken adipose tissue
mainly through the uptake of fatty acids from circulating TAG-rich VLDL delivered
by the liver. Increased VLDL levels were found in virtually all lines of chickens
associated with high fatness, reflecting the critical role of the liver in fatness of
chickens [24]. The contribution of de novo lipogenesis in liver to fat deposition was
also confirmed using the chicken lines selected by plasma VLDL concentration [20].
Low VLDL line chickens were found to be associated with a relative decrease in
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abdominal fat and total body lipid and lipogenic enzyme activity (FASN, ME, ACL)
and an increase in body protein [37].
In the refed state after fasting, both lean and fat line chickens showed elevated
plasma VLDL concentration (14-fold and 7-fold, respectively), reaching similar levels
at last, which indicated that hepatic conversion of glucose to fatty acids is common in
all lines of chickens, and nutrient status may induce a compensating increase of
plasma VLDL in lean line chickens Fat line chickens also showed higher hepatic
VLDL removal rate, other than VLDL secretion [38]. Accordingly, increased
adipocyte number and size result in higher fatty acid uptake rate in adipose tissue [23].
Fat line chickens showed higher LPL activity and its activity was found to be
positively correlated with fat deposition in broilers [23]. Greater LPL activity per cell
was observed not only in genetically fat line chickens, but also in broiler chickens
compared to layers, which exhibited a lower growth rate in both abdominal adipose
mass and body mass [39].
De novo lipogenesis
De novo lipogenesis is an enzymatic pathway that converts acetyl-CoA, the
intermediate of dietary carbohydrate metabolism, to fatty acids. There are three types of
fatty acids based on the number of double bonds, i.e., saturated (SFA, no double bond),
monounsaturated (MUFA, one double bond) and polyunsaturated fatty acids (PUFA, two
or more double bonds). De novo lipogenesis begins with the condensation reaction of
acetyl-CoA with malony-CoA to produce six-carbon intermediates and proceeds by the
serial addition of two-carbon units to synthesize 16-carbon palmitate. Palimitate
undergoes elongation and desaturation (the addition of double bonds) process, leading to
the formation of various PUFAs. PUFAs can be classified into two categories, the n-3
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and n-6 series, depending on the position of the final double bond nearest the terminal
methyl group. Eicosapentaenoic acid [20:5 (n-3), EPA] and docosahexaenoic
acid [22:6 (n-3), DHA] are the most common n-3 long-chain PUFAs. They exert
beneficial functions, i.e., anti-inflammation, anti-obesity and reducing plasma
triglycerides in humans and rodents. The general process of de novo lipogenesis is
shown in Figure 1-1.
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De novo lipogenesis occurs in liver and adipose tissue in a species dependent
manner. In rodents, adipose tissue accounts for about 50% de novo lipogenesis. Whereas
in human and chickens, only 15% of de novo lipogenesis occur in adipose tissue, and the
rest is from liver [41]. The product of de novo lipogenesis in liver are secreted in the form
of VLDL and delivered to other tissues.
Acetyl-CoA carboxylase (ACC) is the rate-limiting enzyme catalyzing the
irreversible carboxylation of acetyl-CoA to produce malonyl-CoA. Two major isoforms
of ACC, ACACA and ACACB, are predominately expressed in adipose tissue and
skeletal muscle, respectively. The other critical enzyme is fatty acid synthase (FASN),
which catalyzes synthesis of palmitate from acetyl-CoA and malonyl-CoA. Fatty acids
are subsequently esterified with glycerol into triglycerides [42]. Lipogenic enzymes, such
as FASN, ME, ACC, ATP citrate lyase (ACL) and steroyl CoA (delta 9) desaturase 1
(SCD1), have relatively low activity in chicken adipose tissue [36, 43]. Expression of
lipogenic enzyme genes is influenced by Sterol regulatory element binding protein-1
(SREBP1) [44, 45]. SREBP1 is more expressed in the liver than adipose tissue, which is
also observed in humans. This may explain the limited de novo lipogenesis in adipose
tissue of both humans and birds.
Although de novo lipogenesis in chicken adipose tissue is limited, it is
regulated by nutritional manipulation. For instance, lipogenesis from acetate was
inhibited by VLDL as an exogeneous source of fatty acids, which was also observed in
mammalian adipose tissue [41]. Likewise, de novo lipogenesis may be enhanced when
excess carbohydrates are consumed.
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Fatty acid uptake, re-esterification and lipolysis
Long chain fatty acids translocate across the plasma membrane through
passive diffusion, and this process is facilitated by membrane associated fatty acid
transport protein (FATPs, SLC27 family). FATP expression in chicken adipose tissue
showed an age- and depot-dependent pattern of expression. Expression in the
abdominal depot increased with age to its highest level at eight weeks of age then
decreased, whereas in subcutaneous fat, it reached a peak at 12 weeks of age[46]. This
observation is consistent with the fact that birds are fatter at an older age.
Fatty acid esterification in adipocytes involves two steps. First, a fatty acid is
activated to its CoA derivatives; second, fatty acyl-CoA is added to the glycerol
“backbone” in adipocytes. The two steps are catalyzed by acyl-CoA synthetase (ACS)
and diacylglycerol acyltransferase 2 (DGAT2), respectively. During this process,
glycerol-3-phosphate (G3P) is formed by phosphorylation of glycerol or synthesized
from pyruvate or lactate, which is catalyzed by phosphoenolpyruvate carboxykinase
(PEPCK). The incorporation of G3P into TAG is catalyzed by glycerol kinase (GK),
which is considered absent in adipose tissue. However, the mechanism and regulation
of these processes in chicken adipose tissue remains unknown.
In mammals, the key enzymes involved in lipolysis of TAG in adipose tissue
include hormone sensitive lipase (HSL) and adipose triglyeride lipase (ATGL).
However, the existence of HSL has not been identified in chickens [47]. In
mammalian adipocytes, HSL was found to form a complex with fatty acid binding
proteins (FABPs), which indicated the lipolytic effect of FABPs. A-FABP
overexpression in chicken adipocytes was found to be associated with lipid
accumulation [48]. Adipose triglyceride lipase (ATGL) is the rate-limiting enzyme in
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TAG lipolysis, and its expression in chicken abdominal adipose tissue is high. A
recent study showed that dexamethasone increased ATGL expression through
activation of glucocorticoid [49], and 24 hours of fasting increased ATGL expression
at both mRNA and protein levels in broiler adipose tissue [50]. Moreover, ATGL gene
polymorphisms were associated with chicken growth and fat traits in an SNP
association study [51]. TAG lipolysis is the procedure that decreases energy storage in
adipose tissue and may be followed by the increase in fatty acid oxidation, resulting in
lean muscle growth, which maximizes feed efficiency and is of critical importance in
animal agriculture. Further studies are needed to explore the mechanism in TAG
lipolysis, and fatty acid oxidation in chicken adipose tissue. These results indicated a
relationship between nutritional status and lipid metabolism and adipogenesis.
Fatty acid oxidation
Fatty acids can be classified as short-chain (SCFAs, C4–C8), medium-chain
(MCFAs, C6–C12), long chain fatty acids (LCFA, C10–C16) and very-long-chain fatty
acids (VLCFAs: C17–C26) based on their length. SCFAs and MCFAs are oxidized
exclusively in the mitochondria. LCFAs long are oxidized in both the mitochondria and
the peroxisomes. Fatty acids longer than 14 carbon atoms are preferentially oxidized in
the peroxisomes.

Fatty acids destined for oxidation are first activated and converted to fatty acylCoA by acyl-CoA synthetases long chain family (ACSL) in the cytoplasm, which is
followed by oxidation in the mitochondria. Fatty acyl-CoA is transported into the
mitochondria via an acyl-carnitine intermediate, which is generated by carnitine
palmitoyltransferase 1 (CPT1), the key enzyme catalyzing mitochondria fatty acid
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oxidation. In humans, three isoforms of CPT1 were identified: CPT1A, mostly express in
the liver, CPT1B, predominately express in the skeletal muscle, and CPT-1C, exclusively
express in the brain and testes. On the inner mitochondria membrane, carnitine
palmitoyltransferase 2 (CPT-2) regenerates fatty acyl-CoA molecules from fatty acylcarnitine.

In contrast to mitochondria, peroxisomes are the site of degradation of VLCFA
and the synthesis of the important PUFA (DHA and DPA) by shortening C24:6ω3 and
C24:5ω6, respectively [52]. Peroxisome fatty acid oxidation is initiated by the ratelimiting enzyme acyl-CoA oxidases (ACOX). This step yields a significant reactive
oxygen species (ROS) by the reduction of O2 to hydrogen peroxide (H2O2). Among three
peroxisomal acyl-CoA oxidases, ACOX1 is the most important oxidase that catalyzes the
oxidation of VLCFA in humans and rodents.
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Figure 1-2. Mechanism of inhibition of glucose utilization by fatty acid
oxidation. The extent of inhibition is graded and most severe at the level of pyruvate
dehydrogenase (PDH) and less severe at the level of 6-phosphofructo-1-kinase (PFK) and
glucose uptake. PDH inhibition is caused by acetyl-CoA and NADH accumulation
resulting from fatty acid oxidation, whereas PFK inhbition results from citrate
accumulation in the cytosol. The mechanism of inhibition of glucose uptake is not clear.
These effects reroute glucose toward glycogen synthesis and pyruvate to anaplerosis
and/or gluconeogenesis. See text for further details. CYTO, cytosol; MITO,
mitochondria , image Image courtesy of Hue, 2009[53].
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Glucose and fatty acids are the major fuels for metabolism and there is an
interaction between their utilization, which is called the glucose-fatty acid cycle.. The
glucose-fatty acid cycle, also termed Randle cycle [54], describes reciprocal regulation of
carbohydrate and fat metabolism. i.e., elevation of plasma non-esterified fatty acid
(NEFA) and fatty acid oxidation inhibit glucose uptake and pyruvate oxidation, and vice
versa (Figure 1-2). This phenomenon is prevalent in skeletal muscle and adipose tissue.

As outlined in Figure 1-2, the process is regulated by pyruvate dehydrogenase
kinase (PDKs). During fatty acid oxidation, activated PDK phosphorylates and inhibit
pyruvate dehydrogenase (PDH), which in turn inhibits pyruvate oxidation. Fatty acid
oxidation also leads to elevated NADH, which consequently activate PDKs. Additionally,
excess acetyl-CoA serves as the substrate for citrate or acetyl-carnitine in the cytosol. The
resultant citrate is an allosteric inhibitor of PFK1 and consequently inhibits glycolysis.

Regulation of Adipose Metabolism
Among the hormones, insulin is studied most often as a regulator of adipose
metabolism due to its important roles in glucose and lipid metabolism. In mammals,
insulin promotes glucose utilization by stimulating glucose transport and inhibiting
lipolysis (Figure 1-3B). The transport of glucose from the plasma membrane to peripheral
tissues is mediated by glucose transporter proteins (GLUT), specifically GLUT4, the
insulin-responsive glucose transporter highly expressed in muscle and adipose tissue in
rodents [55, 56].
Chickens, however, are considered to be refractory to insulin. Chicken is
characterized by the unique features of hyperglycemia and insulin resistance. Chickens
have a high plasma glucose level of 2 g/l in the fed state under normal insulin

18

concentration in circulation [57]. This level would be considered diabetic in human. The
injection of insulin cause slight hypoglycemia in chickens, but the doses are higher than
those required in mammals [57], which indicates the insensitivity of chickens to insulin.
However, insulin does play a role in

glucose homeostasis in chickens, which was

demonstrated by the evidence that immuno-neutralization of insulin largely enhanced
plasma glucose in fed broilers [58]. However, the association of glycemia with adiposity
of chickens differ from that of mammals in that lower fasting plasma glucose levels are
found in fatter chickens [59, 60]. In chicken adipocytes, insulin was found to increase
glucose uptake, glucose oxidation, and lipogenesis [61]. However, the effect of insulin on
adipocytes was thought to be limited compared to the effect of other hormones, such as
glucagon [57].
Not all of the isoforms of glucose transporters in chickens have been identified.
The known isoforms expressed in chickens include GLUT1, which is highest
expressed in the brain and adipose tissue, GLUT2, which is only expressed in liver
and kidney, GLUT3, which is highly expressed in brain, and GLUT8, which is highly
expressed in kidney and adipose tissue [55]. Chicks injected with insulin exhibited a
significant increase in glucose uptake in cardiac tissue, brain, kidney, and skeletal
muscle, but not in cardiac muscle and adipose tissue. This finding suggested that
adipose tissue may be excluded from the insulin-responsive glucose transport
mechanism [62]. This is not surprising because acetate and pyruvate, rather than
glucose, are the major substrates for de novo lipogenesis to produce TAG in chickens,
and glucose is only the precursor for glyceride-glycerol. Insulin actually affects
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lipogenesis by stimulating the incorporation of acetate into lipids, which was observed
in isolated chicken adipocytes [63].
To further understand the mechanism of the regulatory roles of insulin in
chickens, several chicken models were generated by manipulating diet or insulin
deprivation to characterize insulin receptors (IR), as well as other components of the
insulin signaling pathways. These studies revealed that different chicken tissues have
specific responses to insulin. All of these studies proved that the liver is sensitive to
insulinemia in both early steps (IRß, IRS-1, Shc and PI3K) and downstream elements
(Akt, MAPK ERK2, GSK3, P70S6K and S6 ribosomal protein) of insulin signaling
[64-66]. In contrast, muscle showed insulin resistance, but only in the early steps of
insulin signaling [58, 67], whereas adipose tissue was more refractory to insulin than
muscles in both the early steps and downstream elements of insulin signaling cascades
[68]. Moreover, genetically fat and lean line chickens showed apparent differences in
insulin signaling in response to feeding, prolonged fasting and refeeding. Fat line
chickens exhibited higher insulin sensitivity in liver than lean line chickens in terms of
early steps (IRß, IRS-1, Shc and PI3K) of insulin signaling cascade, which would
account for increased liver lipogenesis in fat line chicken [64]. Nevertheless, little
difference was observed in leg muscle of fat line chickens regarding the early steps of
insulin signaling in response to nutritional status, which may be due to consistent
refractory to insulin in muscles [64].
Glucagon is a major lipolytic hormone in chickens [69]. Glucagon binds to
receptors on the surface of adipocytes and catalyzes the production of cyclic AMP
(cAMP) inside the adipocyte [70]. As in mammals, induction of cAMP mediates the
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lipolytic effect of glucagon by activating lipase enzymes. Glucagon-induced cAMP was
much higher in chicken adipocyte than in rat adipocyte; this is probably due to the
variations in the degradation rate of cAMP [71], which may explain the powerful effect
of glucagon in chickens., Other hormones exhibited different effects on chickens. For
instance, growth hormone has both lipolytic and anti-lipogenic effects [72]. Further
studies are needed to elucidate the effects of thyroid hormones (T3 and T4) and insulin
growth factors on adipose physiology and metabolism.
In addition to glucagon, other lipolytic stimuli include catecholamine (i.e.,
epinephrine, norepinephrine and dopamine), melanocortins (i.e., Adrenocorticotrophin
hormone (ACTH) and melanocytestimulating hormone (MSH)), thyroid-stimulating
hormone (TSH) and adenosine [73]. The main pathway leading to lipolysis is the cAMPdependent protein kinase (PKA) pathway (Figure 1-3A).

Through this pathway,

stimulating G protein coupled receptors (GPCRs) and activating downstream signaling
factors like the enzyme adenylyl cyclase lead to increased synthesis of cyclic-AMP
(cAMP) from ATP. Increased level of cAMP subsequently activate PKA, resulting in
lipolysis [74]. Activation of protein kinase C and stimulation of the mitogen activated
protein kinase (MAPK) pathway could also increase lipolytic activity in adipocytes [75].
A recent study found that lipolysis stimulated by β-adrenergic receptor activation,
increasing cAMP levels in white adipocytes of rodents, acutely induces mitochondrial
uncoupling. This process may also contribute to fatty acid oxidation. The effect was
amplified in the absence of which are amplified in the absence of scavenging BSA [76].
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Figure 1-3. Regulation of lipolysis in adipocytes. (A) Desnutrin/ATGL
initiates lipolysis by hydrolyzing triacylglycerol (TAG) to diacylglycerol (DAG).
During fasting, catecholamines, by binding to Gαs-coupled β-adrenergic receptors (βAR), activate adenylate cyclase (AC) to increase cAMP and activate protein kinase A
(PKA). PKA phosphorylates HSL, resulting in translocation of HSL from the cytosol
to the lipid droplet. PKA also phosphorylates the lipid droplet associated protein
perilipin. (B) In the fed state, insulin binding to the insulin receptor (IR), results in
decreased cAMP levels and decreased lipolysis. Insulin also suppresses expression of
desnutrin/ATGL. Image courtesy of Ahmadian, 2010 [74].

22

Because lipid metabolism pathways and adipose physiology are highly
conserved in chickens, hormonal and nutritional regulation of hepatic lipogenesis,
adipose fatty acid uptake and the whole process of adipogenesis are comparable
between chickens and humans. Understanding the mechanisms of hormonal regulation
may also be beneficial in developing new therapies for human obesity.

Mechanisms of Adipose Tissue Expansion
Adipose tissue expands with plasticity to increase TAG uptake and
accommodate lipids that would otherwise be deposited ectopically in tissues not
intended to store significant amounts of lipid. Adipose tissue can expand its storage
capacity by either enlargement of existing adipocytes (hypertrophy) or formation of
new adipocytes (hyperplasia). Adipose expansion also requires increasing the local
vascular supply, and coordinating different cell types, including endothelial precursor
cells, immune cells, and preadipocytes. In humans, adult-onset obesity is associated
with hypertrophy, whereas early-onset obesity in children arises from both adipocyte
hypertrophy and hyperplasia [27]. The development of hyperplasia is regulated by the
growth factors regulating preadipocyte commitment, such as preadipocyte factor-1
(Pref-1, DLK1, SCP-1). Pref1 was found to promote muscle development and inhibit
adipose development in mice and play an important role in the regulation of skeletal
stem cell differentiation in humans [77].
Adipose cellular development in chicken is characterized by hyperplasia early
in life through posthatching to first several weeks of age [78] and it is paralleled by
hypertrophy through adulthood. Genetically fat line and lean line chickens show great
divergence in both adipocyte size and number, despite a similar feed intake and body
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weight [79]. Adipocyte number was two- fold higher in the fat line chickens compared
to the lean line chickens at 2 and 5 week of age [23]. Consequently, cell hyperplasia
led to high LPL activity in adipose tissue of genetically fat line chickens and enhanced
fatty acid uptake in 2-week old fat line chickens [23]. Hypertrophy predominates at
older ages, e.g., 12-14 weeks [41]. Therefore, hyperplasia is responsible for early
development of fat deposition, which may exacerbate adult obesity. This correlates
with the observations in humans that adult-onset obesity is associated with increased
adipocyte size, whereas early-onset obesity has both adipocyte hypertrophy and
hyperplasia [80]. Adipocyte hypertrophy was considered to be more correlated with
excessive fat deposition and more likely to explain the variation of fatness among lines
than hyperplasia [81]. Previous studies also illustrated that the difference in plasma
triglyceride and phospholipids between fat and lean lines was not significant after nine
weeks of age [22], as well as de novo fatty acid synthesis in 15-week-old chickens
[82], but the difference in abdominal fat was still pronounced. This finding indicated
that adipocyte hypertrophy and adipose expansion are probably responsible for the
majority of differences in fatness of fat line and lean line chickens during adulthood.
In chicken adipose tissue, full length DLK1 gene also had a myogenic function
and had higher expression in preadipocytes than adipocytes in an age dependent
manner [83]. Likewise, some growth factors regulate preadipocyte proliferation and
differentiation, such as transforming growth factor-ß (TGFß), insulin-like growth
factors (IGFs) and fibroblast growth factors (FGF). TGFß also has functions to
promote proliferation and inhibit differentiation of adipocytes precursors, which was
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also observed in chickens [84, 85]. TGFßalso reduces LPL activity in accordance with
its anti-lipogenic activity.
A recent study reported the onset of adipocyte hypertrophy as early as five
weeks of age in fat line chickens resulting from the sustained selection pressure on the
fatness trait. And it also demonstrated that the divergence of adipocyte cell number
between the two lines was pronounced from 10 days of age, which indicated ontogenic
variation in chicken adipose tissue due to genetic selection [86].

Endocrine Functions of Adipose Tissue
Adipokines
In addition to its classical role as an energy storage depot, white adipose tissue
is now recognized as an important endocrine organ due to its ability to synthesize and
secret a number of proteins that are collectively referred as adipokines [87]. The term
“adipokines” is defined from “adipose cytokine” because many of adipokines are
cytokines with known roles in immune functions [88]. Obesity is associated with
differentially expression of many adipokines. In general, inflammatory adipkines such
as TNFa and IL-6 are at higher levels in obese vs. lean adipose tissues. Adipokines
are considered as the molecular link between inflammation, obesity, insulin resistance
and other metabolic syndromes in humans [89, 90]. Some adipokines, such as leptin,
adiponectin, resistin and visfatin, are involved in energy and glucose homeostasis.
Adipokines exhibit pro-inflammatory and/or anti-inflammatory effects. For
example, chemokines such as monocyte chemotactic protein 1 (MCP-1) and
interleukin 8 (IL-8), IL-6, IL-1, angiotensin-II (Ang II) and tumor necrosis factor a
(TNF-a), have been implicated to be responsible for the development of insulin
resistance and the increased risk of cardiovascular disease associated with obesity. By
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contrast, induction of anti-inflammatory adipokines, such as IL-10 and adiponectin,
inhibit IL-6 and nuclear factor κB (NF-kB) and lead to increased insulin sensitivity
and elevated fatty acid oxidation [91].
The relationship between adipokines and obesity has been intensively studied
in many other species, including dogs, cats and horses [88], but the relationship in
chickens remains unknown. For example, the existence of chicken leptin remains
debated [92-94], although leptin receptor (LEPR) has been identified in multiple
chicken tissues, including adipose tissue [95-98]. Similarly, TNFa, resistin and
omentin, which are extensively studied in mammals, have not been identified in
chickens. The expression of adiponectin and visfatin in chicken adipose tissues has
been confirmed. Adiponectin is an anti-inflammatory adipokine that enhances insulin
sensitivity and is regulated by C/EBPα in humans [99]. Adiponectin gene expression
in abdominal adipose tissue in broilers was increased with restricted dietary energy
and protein levels, although only at a younger age [100], which was also seen in
humans with low-calorie diet [101]. Visfatin was found associated with obesity [12]
and type 2 diabetes mellitus [102] through mediating insulin secretion in pancreatic
βcells [103]. In chickens, visfatin expression, especially in adipose tissue, was
regulated by the factors related to energy homeostasis in a tissue-specific and sexdependent manner [104]. Therefore, their regulation in adipose tissue of chicken are
still of interest.
Adipose tissue expansion is also associated with immune cells infiltration. A
number of immune cells reside in adipose tissue, including macrophages, mast cells, B-2
cells, CD8+ T cells, IFN-γ+ CD4+ T cells, eosinophils, and regulatory T cells. They exert
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a wide range of functions, which can be detrimental by inducing inflammation and
insulin resistance or be beneficial by protecting against these pathologies [28]. These
immune cells secrete mediators such as IL-6, TNFa, and MCP1 involved in immune
responses. In lean individuals, adipocytes interact with anti-inflammatory immune cells,
such as eosinophils and regulatory T-lymphocytes (Treg). However, in obese individuals,
obesity drives the interaction with inflammatory immune cells and stimulates the
infiltration macrophages (Figure 1-4).
Macrophages that infiltrate adipose tissue contribute to the increased expression
of inflammatory cytokines in obesity in human and rodents [105]. Adipose tissue
macrophages are classified into M1 phenotype which secretes high level of proinflammatory cytokines, such as IL-6 and TNF-α, and M2 phenotype which mainly
secretes anti-inflammatory cytokines, such as IL-10. Adipose tissue from obese animals
give rise to the M1 phenotype by expressing high levels of chemokines, i.e., MCP-1, or
stimulated by TLR4 ligands, i.e., saturated fatty acids. In contrast, macrophages maintain
the M2 phenotype in lean adipose tissue [105]. Little is known about the presence,
recruitment or types of macrophages in chicken adipose tissue. It was found that
lipogenesis in chicken adipocytes, rather than hepatocytes, was increased by conditioned
medium from chicken macrophages [106], which suggest a role for macrophage
infiltration in chicken adipose accumulation.
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Figure 1-4. Schematic representation of adipocyte–immune-cell interactions and the
soluble mediators involved in adipose tissue of lean versus obese individuals. Image
courtesy of Schipper, 2012 [28].
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Genetic Mapping of Fatness-synteny with Human Genetic
Studies of Obesity
For decades, quantative trait loci (QTL) have been used to identify the genes
that affect disease resistance and productivity using different types of genetic crosses.
For this reason, a dense linkage map has been produced to enrich genetic resources.
The availability of genomic and genetic resources, including the genome sequence, the
high-density linkage map, and the newly developed web-based tool Chicken Obesity
Gene Map in Gallus Gbrowse, enable large scale analyses of gene function using
chickens as an animal model for human research. Linkage mapping suggest that the
chicken genome has a better synteny with the human genome than the mouse genome;
there are around 100 conserved synergic groups between chicken and human, which in
mouse and human are 167 [107].
Chicken F2 populations generated from chickens divergently selected for low or
high growth rate and abdominal fatness provide valuable models through which to
integrate phenotypes with genotypes. Genome-wide linkage analyses on F2 populations
have identified QTLs associated with body composition, growth and metabolic traits
[108-110]. Additionally, F2 populations generated from fast-growing broilers male line
and 2 slow-growing inbred lines (Leghorn and Fayoumi) of chicken populations provide
comparative models to study growth and fat deposition in chickens. Genome-wide studies
on these F2 chickens have identified QTLs associated with abdominal fat percentage,
growth and average daily gain, body composition, skeletal integrity and metabolic traits
in the chickens [111-114].
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These studies found that adiposity in chickens is polygenic and under the
control of multiple chromosomal loci, which have high synteny with human obesity.
Most of the genes located on QTL regions for the fatness trait were found to be
obesity and diabetes related genes in humans [115-117]. For example, QTL mapping
of metabolic and body composition traits in F2 intercross between high-growth and
low-growth chicken lines revealed that QTL for fatness and plasma glucose are colocalized on several loci, which control each trait in the same direction [115]. This
finding fits with the metabolic deviations observed in obese humans with
hyperglycemia [115]. Furthermore, GLUT12 gene, which was found associated with
hypertension and diabetic nephropathy in mammals, was targeted for plasma glucose
level by QTL analysis. Additionally, PPARγ, one example of the common genes
mapped with human obesity, was identified to be associated with plasma glucose and
NEFA in this study [115, 117]. Such comparative studies provide unique opportunities
for fully exploring the genetic causes of obesity and T2D in humans.
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CHAPTER II
TRANSCRIPTOMIC AND METABOLOMIC PROFILING
OF CHICKEN ADIPOSE TISSUE IN RESPONSE TO
INSULIN NEUTRALIZATION AND FASTING

This chapter is adapted from the following publication:
Bo Ji, Ben Ernest, Jessica R Gooding, Suchita Das, Arnold M Saxton, Jean Simon, Joelle
Dupont, Sonia Métayer-Coustard, Shawn R Campagna, and Brynn H Voy.
BMC Genomics 2012 13:441.

Abstract
Domestic broiler chickens rapidly accumulate adipose tissue due to intensive
genetic selection for rapid growth and are naturally hyperglycemic and insulin resistant,
making them an attractive addition to the suite of rodent models used for studies of
obesity and type 2 diabetes in humans. Furthermore, chicken adipose tissue is considered
as poorly sensitive to insulin and lipolysis is under glucagon control. Excessive fat
accumulation is also an economic and environmental concern for the broiler industry due
to the loss of feed efficiency and excessive nitrogen wasting, as well as a negative trait
for consumers who are increasingly conscious of dietary fat intake. Understanding the
control of avian adipose tissue metabolism would both enhance the utility of chicken as a
model organism for human obesity and insulin resistance and highlight new approaches
to reduce fat deposition in commercial chickens. We combined transcriptomics and
metabolomics to characterize the response of chicken adipose tissue to two energy
manipulations, fasting and insulin deprivation in the fed state. Sixteen to 17 day-old
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commercial broiler chickens (ISA915) were fed ad libitum, fasted for five hours, or fed
but deprived of insulin by injections of anti-insulin serum. Pair-wise contrasts of
expression data identified a total of 2016 genes that were differentially expressed after
correction for multiple testing, with the vast majority of differences due to fasting (1780
genes). Gene Ontology and KEGG pathway analyses indicated that a short term fast
impacted expression of genes in a broad selection of pathways related to metabolism,
signaling and adipogenesis. The effects of insulin neutralization largely overlapped with
the response to fasting, but with more modest effects on adipose tissue metabolism.
Tissue metabolomics indicated unique effects of insulin on amino acid metabolism.
Collectively, these data provide a foundation for further study into the molecular basis for
adipose expansion in commercial poultry and identify potential pathways through which
fat accretion may be attenuated in the future through genetic selection or management
practices. They also highlight chicken as a useful model organism in which to study the
dynamic relationship between food intake, metabolism, and adipose tissue biology

Introduction
The domestic chicken provides a widespread and relatively inexpensive source of
dietary protein for humans. In addition to its role as a food animal, the chicken has a long
history as a valuable model research organism [118]. These dual considerations led to the
selection of chicken as the first agricultural animal model to be sequenced at the genome
level [119]. While chickens have been used heavily for studies of developmental biology
and immunology, a number of traits make them a viable model for studies of adipose
biology, obesity and insulin resistance. Commercial broiler chickens, in particular,
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rapidly accumulate excess adipose tissue as a result of genetic selection for growth and
are considered “obese” relative to leaner egg-laying or wild strains of chickens (rev. in
[120]). Chickens mimic the early stage of type 2 diabetes in humans, exhibiting both
hyperglycemia (up to 200 mg/dL in the fasting state) and resistance to exogenous insulin
[121, 122]. Like humans, but unlike rodents or pigs, chickens rely on liver rather than
adipose tissue for the majority of de novo lipid synthesis [123-125]. Most metabolic
genes are conserved with humans, and a number of the quantitative trait loci (QTLs) that
have been linked to fatness in chickens contain genes implicated in human susceptibility
to obesity or diabetes [126]. Chickens also represent a model for studying mechanisms of
adipocyte hyperplasia during development, a process that may exacerbate adult obesity.
During at least the first several weeks after hatch, chicken adipose tissue expands more
through adipocyte hyperplasia than hypertrophy, and an early increase in adipocyte
number is a common feature of some lines genetically selected for excess adiposity [11,
127]. Finally, the egg presents opportunities to directly manipulate the developmental
milieu and study the consequences on adipose metabolism via in ovo injection.

Relatively little is known about regulation of adipose tissue deposition and
metabolism in chicken. Because of its relative importance in lipogenesis, most studies
have focused on the role of liver in adipose expansion. Several genetic lines of fat and
lean chickens have been developed through phenotypic selection, most of which have
both elevated plasma levels of VLDL and lower levels of plasma glucose, reflecting the
importance of hepatic lipogenesis and glucose consumption in fat accretion. Reciprocally,
phenotypic selection for low plasma glucose simultaneously selects for fatness [128].
Both chicken and mammalian adipocytes develop through a sequence of molecular

33

triggers including activation of CEBPα and PPARγ [129]. A clear point of divergence,
however, is their responsiveness to insulin. Unlike in mammals, insulin has minimal
effect on glucose uptake in chicken adipose tissue [62]. In fact, an avian homolog of the
insulin-sensitive glucose transporter GLUT4 has not been identified in the current
chicken genome database. Insulin does, however, stimulate uptake of acetate, which is
the preferred substrate for de novo lipogenesis in chicken adipocytes, although the
magnitude of the effect is relatively modest [130]. Insulin signaling appears to proceed
through tissue specific cascades in chicken metabolic tissues. In liver, insulin elicits a
signaling cascade that parallels the response in mammals, including tyrosine
phosphorylation of insulin receptor β-subunit (IRβ), insulin receptor substrate-1 (IRS-1)
and
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phosphatidylinositol 3-kinase (PI3K) [65, 131]. The situation in skeletal muscle is more
complex. Tyrosine phosphorylation of IRβ and IRS-1 and PI3K activity are not regulated
by insulin, whereas events downstream of PI3K (e.g. Akt and P70S6K activation) are
accordingly sensitive [58]. We recently reported that insulin also does not elicit a
classical IRβinitiated cascade in chicken adipose tissue, including the downstream steps
of Akt and P70S6K activation [132]. Insulin also does not inhibit lipolysis in chicken
adipose tissue; glucagon, is the primary lipolytic hormone (rev. in [133]).

In the present study we simultaneously characterized the effects of a short term (5
hours) fast or neutralization of insulin action (5 hours) on adipose tissue of young (16–17
day-old), fed commercial broiler chickens. The goals of this study were two-fold. First,
we sought to identify pathways activated by feed restriction, reasoning that they may
highlight potential strategies for control of fatness through either genetic selection or
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improved management practices. Simultaneously, we sought to understand the
contribution of insulin, if any, into chicken adipose physiology. No experimental model
of diabetes exist in chicken: total pancreatectomies are not achievable, and alloxan and
streptozotocin are inefficient at destroying pancreatic chicken beta-cells (rev. in [122]).
The two treatments were compared to distinguish potential insulin-specific changes from
those that could be mimicked by fasting through changes in nutrient availability. Both
treatments were shown previously to elicit significant alterations in several plasma
metabolic and endocrine parameters [58]; in the studies reported herein, samples of
abdominal adipose tissue were issued from the same experiment. Tissue metabolomics
was combined with microarrays to bridge the gap between gene expression, metabolic
and physiological responses, and to identify the composite effects of both fasting and
insulin deprivation on chicken adipose tissue.

Materials and Methods
Animals

Male broiler chicks (ISA 915, Institut de Seĺection Animale, Saint Brieuc, France)
from which samples were collected for this study were hatched and raised under standard
conditions, as originally described by Dupont [58] and in accordance with the guidelines
for Care and Use of Agricultural Animals in Agricultural Research and Teaching. Briefly,
at 16–17 days of age, chicks of similar body weights were either allowed to continue
feeding (ad libitum fed controls), fasted for five hours, or fed but injected at 0, 2 and 4
hours with porcine anti-insulin serum (insulin neutralized). Both the fed and fasted
groups received injections of normal porcine serum as a vehicle control. Abdominal
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adipose tissue samples were harvested and rapidly snap-frozen in liquid nitrogen,
pulverized, then stored at -80°C until analysis. Adipose samples from five birds in each
group were used for both microarray and metabolomic analyses.

Gene expression

Total RNA was isolated from chicken adipose samples using the RNeasy Lipid kit
and incorporating an on-column DNase treated with the RNase-free DNase Set according
to the manufacturer's protocol (Qiagen.com). RNA quality and concentration were
measured using the Experion System (Bio-Rad.com); only RNA passing recommended
standards of quality was used for further studies. Transcriptome profiling was performed
by Genome Quebec (Montreal, Canada) using the Affymetrix GeneChip Chicken
Genome Array (San Diego, CA). Microarray data from this study are deposited in the
Gene Expression Omnibus (GEO) under the accession number GSE35581. For real time
RT-PCR validation, cDNA was synthesized using the iScript cDNA Synthesis kit (BioRad.com). Commercially designed and validated primer sets (QuantiTect) and the
associated SYBR Green master mix (Qiagen.com) were used to assay gene expression on
a CFX96 real-time PCR detection system (Bio-Rad.com). All samples were analyzed in
triplicate and normalized to ß-tubulin. Relative differences in gene expression were
determined using the 2-ΔΔCT method and statistical differences were tested by analysis of
variance (ANOVA) [134].
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LC-MS/MS

Abdominal adipose tissue samples from five birds in each treatment group (the
same five birds used for expression profiling) were extracted by placing tissue in a mortar
containing liquid nitrogen and then powdering with a pestle. Portions (8–40 mg) of the
powered tissue were weighed into 1.5 mL centrifuge tubes. Chilled methanol (0.5 mL at
−80°C) and internal standard (5 μL of 1.7 mM benzoic acid in negative mode or 4.25 mM
tris(hydroxymethyl)aminomethane in positive mode) were added to each tube. Each tube
was mixed thoroughly by vortexing for two minutes, and the metabolites were extracted
from the tissue for 30 min at 4°C. The tubes were then centrifuged (5 min, 4°C, 16.1 rcf)
and supernatant (210 μL) was split into two autosampler vials. One of these samples was
immediately placed on the LC-MS/MS for analysis, while the other was stored at −80°C
for analysis in the opposite polarity ion mode on the following day.
Samples were placed in an autosampler tray chilled to 4°C, and 10 μL of each was
injected onto an LC column for analysis. The chromatography method for positive ion
mode was reported previously by Bajad and coworkers [135], with one exception that the
column was cooled to 10°C. The chromatography method for negative ion mode was
performed as reported by Waters and coworkers [136], except the gradient was allowed
to run 50 min instead of 45 min to allow more thorough equilibration of the column. The
eluent was introduced directly into the MS via an electrospray ionization (ESI) source
fitted to a Finnigan TSQ Quantum Discovery Max triple quadrupole MS (Thermo
Electron, Waltham, MA) through a 0.1 mm internal diameter fused silica capillary. The
spray voltage was 4500 V in positive mode or 3000 V in negative mode. The sheath gas
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(nitrogen) was set to 40 psi, and the capillary temperature was set to 290°C. The collision
cell gas (argon) was set to a pressure of 1.5 mTorr. Samples were analyzed using selected
reaction monitoring (SRM) mode with a scan width of 1 m/z and a scan time of 0.05 s.
The SRM parameters for most metabolites have been published previously [135]. This
method was used to scan for almost 300 metabolites. Xcalibur software (Thermo
Scientific, Waltham, MA) was used to manually assess the elution time of the correct LC
spectral peak for each metabolite-specific SRM. The Quan Browser utility in Xcalibur
was then used to integrate the LC spectral peak area (in ion counts) for each detected
compound, and these data were exported to a Microsoft Excel spreadsheet for further
processing.

Statistical analysis

Statistical analysis of the microarray data was performed using R 2.9.0 and
routines contained in Bioconductor (bioconductor.org). GC robust multi-array average
(GCRMA) was used to normalize and scale the raw data from CEL files. The normalized
data were filtered for low expression by removing any probes with normalized expression
less than 3 in at least 5 arrays. Statistical significance of gene expression differences were
analyzed by one-way ANOVA and empirical bayes using the limma package. Differential
expression was defined based on false discovery rate (FDR) adjusted p-value <0.05 [137].
Venn diagrams of differentially expressed genes were plotted to visualize the number of
differentially expressed genes for each treatment comparison and their intersections.
Hierarchical clustering of significant genes was performed using the hclust function and a
hierarchical clustering heatmap was created using heatmap.2 in the gplots package.
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Hierarchical clustering also was used to identify correlated patterns of gene expression
and metabolites. The Database for Annotation, Visualization and Integrated Discovery
(DAVID, version 6.7) and ClueGO, a Cytoscape plug-in, were used for Gene Ontology
(GO) at level 6 and 7 and KEGG analysis of differentially expressed genes [138, 139].
Statistical analysis of metabolomic data was performed using an analysis tool that we
developed specifically for metabolomic data analyses [140]. The script (metabR), written
in the language R, uses linear mixed-effect modeling to normalize metabolomics data
containing both fixed- and random-effect confounding variables. The script averages any
replicate measurements (statistical sampling) made on experimental units and performs
ANOVA to test for statistical differences between experimental groups.

Results
Expression levels of a total of 2016 genes were significantly altered by fasting
and/or insulin neutralization when compared to fed controls based on an FDR adjusted pvalue < 0.05 (Additional file 1; Figure 2-1A). Sixty-nine percent of these genes showed a
fold-change ≥ |1.5| (Figure 2-1B). The majority of changes in expression were attributable
to fasting, with 917 up-regulated and 863 down-regulated genes in fasted vs. fed adipose
tissue. Insulin neutralization altered expression of 92 genes, 72 of which were also
differentially expressed with fasting (Figure 2-1A). All genes that were affected by both
treatments changed in the same direction (i.e., up- or down-regulated in both groups).
Real-time RT-PCR was employed to validate differential expression based on the
microarray data. Eleven genes were selected based on fold-change or biological functions
of interest (Table 2-1). Differential expression under fasting versus fed conditions was
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validated for all genes except pre-B-cell leukemia homeobox 3 (PBX3). Ten of the eleven
genes were also differentially expressed in insulin neutralized compared to fed birds
based on QPCR.

Genes that were differentially expressed in at least one pairwise comparison were
clustered to visualize the similarities between groups and to determine if insulinneutralized expression profiles were more similar to fasted or to fed status. As shown in
Figure 2-2A, samples within each of the three experimental groups clustered together.
The dendrogram also showed that the fasting group was distant from fed and insulinneutralized groups, which were closer to each other. To further visualize relationships
between treatments with regard to gene expression, distinct clusters of genes were
extracted and submitted to gene set enrichment analysis to identify GO terms and
pathways that were significantly overrepresented among genes contained in these clusters.
Seven clusters represented four general patterns of similarities between treatments
(Figure 2-2B). Clusters 1, 3 and 4 consisted of genes with higher expression in fasting
compared to both insulin-neutralized and fed conditions, with insulin-neutralized
intermediate between fasted and fed. This set of genes was significantly enriched in GO
terms related to protein and lipid catabolism and to cell signaling, including regulation of
the stress-sensitive NFκB cascade (Table 2-2). These three clusters were also enriched in
members of the KEGG pathways ubiquitin mediated proteolysis, sphingolipid
metabolism, PPAR signaling, fatty acid metabolism and the peroxisome. The ratelimiting genes for fatty acid oxidation (ACOX1 and CPT1A), along with fatty acid
binding proteins 5 and 6, are contained in these three clusters. Clusters 5 and 7 also
contained genes with higher levels in fasted vs. the other two groups, but with
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comparable expression levels between insulin-neutralized and fed, and thus no clear
effect of insulin loss.

These two clusters were significantly enriched in pathways related to signaling
and metabolism, including enzyme linked receptor protein signaling pathway (p = 0.0097)
and in the KEGG pathways for glycerolipid metabolism and PPAR. Genes responsible
for the latter enrichment include PPARΔ, which was recently shown to increase total
oxidative metabolism in white adipose tissue [141]. Clusters 2 and 6 contained genes
expressed at lowest levels in fasted chickens. Genes in cluster 2 were expressed at
intermediate levels in the insulin-neutralized group relative to fed and fasted. This set of
genes was significantly enriched in GO annotations related to monosaccharide catabolic
process and glucose metabolism, and in genes comprising the KEGG pathways for
carbohydrate metabolism, TCA cycle and glycolysis (Table 3-2). Finally, cluster 6
consisted of genes that were also lowest in fasting but showed no clear effect of insulin
loss, with similar expression in fed and insulin-neutralized groups. This set of genes was
significantly enriched for the KEGG pathways steroid biosynthesis (p = 0.0043),
glyoxylate and dicarboxylate metabolism (P = 0.012) and pyruvate metabolism
(P = 0.033), along with a number of genes involved in lipid biosynthesis, which was the
highest scoring GO category (p = 0.6). Cluster 8 was a distinct, small cluster with variable
expression within group and no significant GO or KEGG annotations.

Global biological responses to fasting and to insulin neutralization were further
characterized using KEGG pathway matching, based on genes with statistically
significant differential expression (FDR < 0.05) and absolute fold-change ≥1.5. Genes

41

altered exclusively by fasting represented a wide range of cellular pathways, indicating
significant effects of even a five hour fast on adipose function and metabolism in chicken.
Fasting exerted significant effects on pathways related to carbohydrate, amino acid and
lipid metabolism and synthesis. Within the categories related to lipid metabolism, fasting
up-regulated expression of genes involved in fatty acid oxidation (e.g., acyl-CoA oxidase
1 (ACOX1), acetyl-CoA carboxylase beta (ACACB), carnitine palmitoyltransferase 1A
(CPT1A)) and down-regulated expression of genes that control fatty acid, cholesterol and
triacylglycerol

synthesis

(e.g.,

1-acylglycerol-3-phosphate

O-acyltransferase

9

(AGPAT9), ATP citrate lyase (ACLY), farnesyl diphosphate synthase (FDPS), acetylCoenzyme A carboxylase alpha (ACACA) and acetoacetyl-CoA synthetase (AACS)).
Fasting also up-regulated expression of many genes involved in proteolysis and amino
acid degradation. In addition to pathways highlighted by KEGG analysis, fasting downregulated a number of genes (e.g., TGFβ, BMP) that mediate mesenchymal stem cell
(MSC) commitment, an early step in the formation of new adipocytes (Additional file 1).
Finally, a number of phosphodiesterases were up-regulated with fasting, presumably in
response to the increased plasma glucagon [58] and subsequent elevations in cyclic
adenosine monophosphate (cAMP; Additional file 1). Collectively, these categories
indicate that chicken adipose tissue responds to a relatively short duration (five hour) fast
with sweeping changes in gene expression that suppress synthesis and storage of lipids
and other macromolecules and up-regulate mobilization and metabolism of fatty acids
and proteins.
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Figure 2-1 Venn diagram of overlapping and unique effects of fasting and insulin
neutralization on gene expression. (A) A total of 2016 unique genes were differentially
expressed (FDR adjusted p-value <0.05) between one or more pairwise treatment
comparisons; (B) A total of 1401 genes with absolute fold change ≥1.5 among the
differentially expressed genes
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Figure 2-2 Cluster analysis of differentially expressed genes. (A). Hierarchical cluster
analysis of the 2016 genes (FDR adjusted p-value <0.05) that were differentially
expressed between insulin-neutralized vs. fed and/or fasted vs. fed states. (B) Seven
clusters (numbers) representing the most distinct effects of treatment were selected to
further analyze expression profiles across treatments. Sample ID number on the X-axis
corresponds to treatment group: sample 1–5, fasted; 6–10, insulin neutralized; 11–15,fed
control. Y-axis represents relative gene expression value
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Table 2-1 Fold change verification of gene expression by RT-PCR
Microarray
Fold Change
Fasting
vs.
Fed
4.16***

Ins-Neu Ins-Neu
vs.
vs.
Fed
Fasting
2.09**-1.99***

Quantitative PCR
Fold Change
Fasting
Ins-Neu
vs.
vs.
Fed
Fed
2.59***
2.76***

9.43***

1.05 -8.98***

8.13***

1.69*** -4.82***

2.98***

1.53 -1.95**

3.45***

2.26*** -1.52*

-1.62***

1.07 1.75***

-1.22

1.83*** 2.22***

1.74***

1.02 -1.71**

1.76***

1.42*

-1.24

2.43*

-1.58 -3.86**

2.58***

-1.36

-3.52***

NGFI-A binding protein 2.43***
1 (EGR1 binding protein
1)
Pyruvate dehydrogenase 17.28***
kinase, isozyme 4
Cathepsin L2
2.09***

1.06 -2.29***

1.67**

1.52** -1.10

7.06**-2.45**

18.33***

4.01*** -4.57***

1.55* -1.35*

2.96***

2.053***-1.44

Angiotensin II receptor, 4.15 ***
type 1
Sestrin 1
1.86**

2.05* -2.02**

3.52**

1.72*

-2.05*

1.125 -1.65

1.58*

1.47*

1.07

Gene Symbol Gene Title
FBXO8

F-box protein 8

DUSP5

Dual specificity
phosphatase 5
BCL2/adenovirus E1B
19kDa interacting
protein 3
Pre-B-cell leukemia
homeobox 3
Interleukin 10 receptor,
beta
Early growth response 1

BNIP3

PBX3
IL10RB
EGR1
NAB1

PDK4
CTSL2
AGTR1
SESN1

FDR p-value: * p < 0.05, ** p < 0.005, *** p < 0.0005

45

Ins-Neu
vs.
Fasting
1.06

Table 2-2 Gene ontology (GO) and KEGG annotation for representative clusters of
differentially expressed genes
Cluster
Annotat GO term (Biological Process, level 6 or 7) or KEGG
FDR
ion
pathway name
p-value
1, 3 and 4 GO
Positive regulation of protein metabolic process
6.0 E-3
(731
Negative regulation of cellular macromolecule biosynthetic
7.3 E-3
genes)
process
Triglyceride metabolic process
1.0 E-2
Negative regulation of gene expression
1.0 E-2
Proteolysis involved in cellular protein catabolic process
1.0 E-2
Negative regulation of kinase activity
1.5 E-2
Regulation of transcription, DNA-dependent
2.1 E-2
Protein phosphorylation
3.3 E-2
Antigen receptor-mediated signaling pathway
3.3 E-2
Regulation of phosphate metabolic process
3.4 E-2
Regulation of kinase activity
3.4 E-2
Regulation of I-kappaB kinase/NF-kappaB cascade
3.5 E-2
KEGG
Ubiquitin mediated proteolysis
1.0 E-2
Sphingolipid metabolism
1.8 E-2
PPAR signaling pathway
2.4 E-2
Fatty acid metabolism
4.6 E-2
Peroxisome
5.0 E-2
Monosaccharide catabolic process
2.5 E-2
2
GO
(557
3.6 E-3
DNA dependent DNA replication
genes)
Hexose metabolic process
1.1 E-2
Glucose metabolic process
1.4 E-2
Regulation of cell shape
1.5 E-2
DNA replication
1.5 E-2
Nucleoside triphosphate metabolic
2.3 E-2
KEGG
Glycolysis / Gluconeogenesis
4.9 E-4
Citrate cycle (TCA cycle)
8.9 E-4
6
KEGG
Steroid biosynthesis
4.4 E-3
(402
Glyoxylate and dicarboxylate metabolism
1.2 E-2
genes)
Pyruvate metabolism
3.3 E-2
Enzyme
linked
receptor
protein
signaling
pathway
9.7 E-3
5 and 7
GO
(250
Regulation of cellular protein metabolic process
3.1 E-2
genes)
Negative regulation of macromolecule metabolic process
3.5 E-2
Transmembrane receptor protein serine/threonine kinase
3.6 E-2
signaling pathway
KEGG
PPAR signaling pathway
1.0 E-4
Glycerolipid metabolism
1.8 E-2
MAPK signaling pathway
4.6 E-2
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Loss of insulin action also resulted in significant effects on adipose gene
expression, the majority of which overlapped with the response to fasting (Table 2-3;
Additional file 2). Several genes central to energy metabolism were affected.
Diacylglycerol O-acyltransferase homolog 2 (DGAT2), which catalyzes the final and
only committed step in tracylglycerol synthesis, was down-regulated (10.5-and 6.1-fold,
respectively, fasted and insulin neutralized) in both treatment groups relative to the fed
group. Conversely, acyl-Coenzyme A binding domain containing 5 (ACBD5) and
pyruvate dehydrogenase kinase 4 (PDK4) were significantly up-regulated in both
treatments relative to fed controls. ACBD5 is one of a family of long chain fatty acyl
CoA trafficking protein proteins that play roles in both triglyceride synthesis and betaoxidation [142]. PDK4, which was up-regulated vs. fed by ~ 17-fold with fasting and 6fold with insulin neutralization, acts as a fuel switch by phosphorylating and inactivating
pyruvate dehydrogenase, shifting metabolism from glycolysis to fatty acid oxidation
[143]. Fasting and insulin neutralization also up-regulated expression of the type I
angiotensin II receptor (AGTR1). Angiotensin II alters adipocyte lipid metabolism and
insulin signaling [144-146], and increased AGTR1 expression in adipose tissue is
associated with enhanced insulin sensitivity [147]. Finally, a number of genes regulated
by both fasting and insulin neutralization function in general processes related to protein
synthesis.

A total of thirteen genes (four up-regulated and nine down-regulated) were
differentially expressed only with insulin neutralization (Table 2-4). The most interesting
of these responses were upregulation of GCG, which encodes preproglucagon (fold
change = 2.91), in parallel with downregulation of the glucagon receptor (LOC425670,
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fold change = −2.77). Other genes uniquely affected by insulin have less clear relevance
to adipose biology according to current knowledge.
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Table 2-3 Shared effects of fasting and insulin-neutralization on differential gene
expression

Gene Title

Fold change
Insu-Neu vs. Fed

Fold change
Fasting vs. Fed

PDK4

pyruvate dehydrogenase kinase,
isozyme 4

7.06

17.28

AOX1

aldehyde oxidase 1

2.94

6.66

2.41

2.77

2.09

4.15

2.04

4.15

1.99

2.25

1.97

3.86

Gene Symbol
Up-regulated genes

FBXO8

pleckstrin homology domain
containing, family H (with MyTH4
domain) member 2
F-box protein 8

AGTR1

angiotensin II receptor, type 1

PLEKHH2

PCMTD1
PSME4

protein-L-isoaspartate (Daspartate) O-methyltransferase
domain containing 1
proteasome (prosome, macropain)
activator subunit 4

ICA1

islet cell autoantigen 1, 69kDa

1.85

2.8

IP6K2

inositol hexakisphosphate kinase 2

1.77

2.75

1.72

1.89

1.72

2.51

UHRF2
ACBD5

ubiquitin-like, containing PHD and
RING finger domains, 2
acyl-Coenzyme A binding domain
containing 5

LOC417776

similar to hypothetical protein

1.62

1.84

CTSL2

cathepsin L2

1.54

2.09

ZNF217

zinc finger protein 217

1.54

2.6

1.52

3.47

6.1

10.5

2.4

2.17

2.19

1.98

Interferon (alpha, beta and omega)
receptor 1
Down-regulated genes
diacylglycerol O-acyltransferase
DGAT2
homolog 2 (mouse)
endonuclease/exonuclease/phosphat
EEPD1
ase family domain containing 1
ANKRD9
ankyrin repeat domain 9
IFNAR1
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Table 2-3 Continued
Gene Symbol

Gene Title

Fold change
Insu-Neu vs. Fed

Fold change
Fasting vs. Fed

1.95

1.76

1.8

2.3

1.76

1.74

1.73

1.57

1.71

2.2

1.69

2.37

1.63

1.58

1.6

2.52

1.57

1.51

1.56

1.61

1.56

1.82

1.55

1.71

Down-regulated genes

DLST
PTP4A3
HSPA5
NOLA2
MST1R
GRAMD2
DHDDS
DYNLL2
CDT1
FAHD1
DOT1L
BTBD11

dihydrolipoamide Ssuccinyltransferase (E2 component
of 2-oxo-glutarate complex)
protein tyrosine phosphatase type
IVA, member 3
heat shock 70kDa protein 5
(glucose-regulated protein, 78kDa)
nucleolar protein family A, member
2 (H/ACA small nucleolar RNPs)
macrophage stimulating 1 receptor
(c-met-related tyrosine kinase)
GRAM domain containing 2
dehydrodolichyl diphosphate
synthase
dynein, light chain, LC8-type 2
chromatin licensing and DNA
replication factor 1
fumarylacetoacetate hydrolase
domain containing 1
DOT1-like, histone H3
methyltransferase (S. cerevisiae)
BTB (POZ) domain containing 11

FDR p-value <0.05
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Tissue metabolomic analysis was used to identify the metabolic intermediates that
were altered by fasting and insulin neutralization. A total of 92 metabolites were detected
based on signal-to-noise ratios (Additional file 3). It is worth noting that glucose-6phosphate content was similar in fasted or “diabetic” vs. fed status, despite a large range
of plasma glucose levels (232–747 mg/100 ml). A total of 12 metabolites were
significantly different between treatment groups based on p < 0.05 and an additional five
were suggestive of significance (p < 0.10; Table 2-5). Tissue levels of amino acids were
consistently lower in fasted vs. fed tissue, with statistically significant reductions in
asparagine and glutamine (p < 0.01). Presumably, these effects were due to a change in
the balance of protein synthesis/proteolysis and to the catabolism of carbon skeletons for
energy in response to energy restriction, which is consistent with up-regulated expression
of genes involved in amino acid catabolism (Figure 2-3). They may also reflect a
decrease in plasma amino acid supply as suggested by the decrease in total plasma amino
acid levels (evaluated by the content in total α-NH2-non-protein nitrogen (αNH2NPN),
i.e., mostly total amino acids), as compared to fed controls [58]. In contrast to fasting,
tissue amino acid levels tended to be increased in insulin-neutralized vs. fed, although
only glutamine showed a statistically significant response. Comparison of insulinneutralized vs. fasted chickens highlights the divergent effects of treatments on amino
acids (Figure 2-4). Alanine, arginine, asparagine, glutamine, histidine, proline, serine,
threonine and tyrosine levels were all significantly higher in insulin-neutralized vs. fasted,
with differences ranging from 1.7- to 3.4-fold. Two metabolites related to glucose
metabolism, D-glucono-1,5-lactone 6-phosphate and glycerol-3-phosphate, were lower in
both fasted and insulin-neutralized treatments vs. fed, with the latter comparison nearing
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statistical significance (p < 0.1). D-glucono-1,5-lactone 6-phosphate is a product of
glucose-6-phosphate dehydrogenase (G6PDH), an enzyme that, in mammals is insulinsensitive and rate-limiting for pentose phosphate pathway activity and production of
cellular NADPH, an important cofactor for lipid metabolism [148]. However, pentose
phosphate pathway activity is intrinsically low in chicken and is not stimulated when
lipogenesis is high; the production of cellular NADPH is more closely related to malic
enzyme activity [149]. Glycerol-3-phosphate is a product of both glucose and pyruvate
metabolism and is used in triacylglycerol synthesis. Lower levels with both treatments
may reflect glycerol demand for fatty acid reesterification in light of the apparent
increase in lipolysis in both treatment groups [58].

Correlated patterns of gene expression and metabolite abundance were extracted
using hierarchical clustering to interconnect treatment effects on transcripts and
metabolites. Clusters 2 and 3 contained genes and metabolites with lower abundance in
fasted vs. fed or insulin neutralized tissue. The two clusters differed with respect to the
insulin neutralized group: cluster 3 contained analytes at intermediate levels between
fasted and fed, while cluster 2 contained those at levels comparable to or greater than fed.
Twelve of the 17 metabolites with statistically suggestive or significant effects of
treatment, including all of the amino acids and amino acid derivatives (Additional file 4),
were present in cluster 2 along with a set of genes that included the p85α regulatory
subunit of PI3 kinase (PIK3R1), as well as ME, malonyl CoA decarboxylase and
ELOVL6. Cluster 3 contained several metabolites including both NAD + and NADPH
and was significantly enriched in GO annotations related to carbohydrate metabolism and
in the KEGG pathways TCA cycle, glycolysis/gluconeogenesis, pyruvate metabolism and
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steroid biosynthesis (p < 0.05; Additional file 4). Clusters 7 and 8 consisted of genes and
metabolites with higher levels in fasted than in the other two treatment groups. These
clusters were significantly enriched in GO categories PPAR signaling and negative
regulation of cellular biosynthesis and also contained citrate and pyruvate (p < 0.05;
Additional file 4).

Discussion
Despite roles as both a domestic food animal of worldwide economic importance
and a widely used model organism with relevance for human obesity and insulin
resistance, few studies have examined regulation of gene expression in chicken adipose
tissue. To our knowledge, no studies of nutritional regulation of chicken adipose tissue at
the genomic level have been reported in the published literature. Likewise, although
insulin is the most well-defined hormonal mediator of metabolism in mammalian adipose
tissue, its role in chicken remains to be clarified. Therefore the current study addressed
two objectives: 1) characterize the transcriptomic and metabolomic response to energy
manipulation as a step toward enhanced understanding of adipose biology in chicken; and
2) identify the effects of insulin on chicken adipose tissue by including a group of birds in
which insulin action was blocked by immunoneutralization with an anti-insulin antibody.
We sought to both identify potential new targets for genetic selection or management
strategies to reduce fat accumulation in commercial broilers and to further develop
chicken as a model organism for studies of human obesity.

Although intrinsic lipogenic activity is low in chicken adipose tissue, genes
involved in fatty acid synthesis and storage were suppressed and those in fatty acid
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mobilization and oxidation were up-regulated by fasting. The 40 down-regulated genes
with fold changes greater than three were significantly enriched for the GO annotation
lipid biosynthetic process (FDR <0.05), including genes that control triglyceride
synthesis (DGAT2 and AGPAT9) and fatty acid synthesis (ACACA, ACLY and ME),
elongation (ELOVL6), and desaturation (FADS1). AGPAT9 and DGAT2 catalyze the
initial and final steps, respectively, of de novo triglyceride synthesis. ACLY is the main
enzyme for synthesis of cytosolic acetyl-CoA, which is carboxylated to malonyl-CoA by
ACACA, the rate-limiting step in fatty acid synthesis. Reducing equivalents for the
conversion of malonyl-CoA to palmitate are supplied by malic enzyme (ME). ELOVL6
catalyzes elongation of palmitate to stearate and appears to play a key role in insulin
sensitivity [150, 151]. Finally, FADS1 is rate-limiting for polyunsaturated fatty acids
(PUFA) biosynthesis and was recently implicated in control of fasting glucose
homeostasis in humans [152]. Genes altered by fasting in adipose tissue in this study
overlapped with those shown to be differentially expressed in chicken liver after 16 or 48
hours of fasting, including ACLY, ACOX1, BCAT1 and PDK4 [153]. These authors
used a different array platform than ours, which precludes precise quantitative
comparisons.
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Table 2-4 Unique effects of insulin neutralization on differential gene expression
Up-regulated genes
Down-regulated genes
Gene
Symbol

Gene
Title

GCG

Glucagon

2.91

LOC425670

TCP11L2

t-complex
11 (mouse)like 2

2.08

BAK1

LOC416916

hypothetical
LOC416916

1.98

CCT3

MAGI1

membrane
associated
guanylate
kinase, WW
and PDZ
domain
containing 1

SEPT10

septin 10

LSM14A

LSM14A,
SCD6
homolog A
(S.
cerevisiae);
similar to
LSM14
homolog A
(SCD6, S.
cerevisiae)

Fold
change

1.84

1.79

1.71

Gene Symbol

Gene Title
glucagon
receptor
precursor
BCL2antagonist/killer
1
chaperonin
containing
TCP1, subunit 3
(gamma)

Fold
change
2.77

1.83

1.62

SETD7

SET domain
containing
(lysine
methyltransferas
e) 7

1.62

ST13

suppression of
tumorigenicity
13 (colon
carcinoma)
(Hsp70
interacting
protein)

1.62

AHSA1

AHA1, activator
of heat shock
90kDa protein
1.62
ATPase homolog
1 (yeast)

TOE1
AZIN1
FDR p-value <0.05
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target of EGR1,
member 1
(nuclear)
antizyme
inhibitor 1

1.59
1.56

Table 2-5 Fold change of fasting and insulin neutralization on adipose tissue
metabolites
Metabolite
Fasting/Fed Ins-Neu/Fed Ins-Neu/Fasting
Adenosine
0.57
1.21
2.12*
Alanine
0.66
1.57
2.38***
Arginine
0.75
1.34
1.78**
Asparagine
0.47***
1.00
2.15***
D-glucono-d-lactone-6-phosphate 0.86
0.75*
0.87
Glutamine
0.48***
1.64*
3.43****
glycerol-3-phosphate
0.82
0.72*
0.87
Histidine
0.64
1.38
2.17***
Hypoxanthine
1.31
0.80
0.61**
N-acetyl-glutamate
0.64
1.34
2.09*
N-acetyl-L-serine
0.23**
1.70
7.30***
Ornithine
0.77
1.59
2.05*
Proline
0.63
1.50
2.39***
Serine
0.67
1.61
2.39***
Threonine
0.77
1.38
1.80**
Tyrosine
0.74
1.30
1.76**
a hexose-phosphate
1.05
1.32**
1.26*
* p < 0.10, ** p < 0.05, *** p < 0.01, **** p < 0.001
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However, among the genes changed in both studies, the fold changes observed in
adipose tissue were consistently greater than those in liver, despite the longer duration of
fasting in that study. For example, PDK4 expression was up-regulated ~ 18-fold by a five
hour fast in adipose tissue, but only ~ 1.5-fold after a 16 hour fast in liver. While
differences in sensitivity between the two array platforms must be kept in mind, these
data suggest that adipose tissue metabolism in chicken is at least as sensitive to energy
status as hepatic metabolism. Our results indicate that both fatty acid synthesis and
storage are dynamically regulated by energy status in chicken adipose tissue, despite its
modest (~ 15%) contribution to the amount of stored fatty acids.

Both fasted and insulin-neutralized birds exhibited significant increases in plasma
glucagon. Parallel elevations in plasma NEFA suggested that this resulted in significant
lipolysis of stored triacylglycerol in both treatment groups. During fasting, a considerable
percentage of the liberated fatty acids are re-esterified in adipocytes, and only a small
fraction traditionally have been thought to be oxidized in the mitochondria of adipocytes
through beta oxidation [154]. However, recent studies in mice and in human adipose
tissue demonstrate that in some conditions fatty acid oxidation in white adipose tissue is
considerable and may be an important determinant of obesity [155-157]. Consistent with
this concept, we found significant increases in a number of key enzymes that mediate
mobilization of fatty acids and their oxidation, including the rate-limiting enzymes in
both mitochondrial and peroxisomal fatty acid oxidation (CPT1A and ACOX1,
respectively). We measured tissue levels of beta-hydroxybutyrate, a ketone product of
beta oxidation, to confirm that changes in gene expression had functional consequences
and found them to be significantly elevated in adipose tissue of fasted vs. fed chickens.
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Levels were numerically but not statistically higher in insulin-neutralized adipose tissue
(data not shown). Qualitatively, fasting-induced changes in gene expression resemble
those induced by the fibrate class of drugs, which activate PPARα and promote fatty acid
oxidation in white adipose tissue and are used clinically to treat hyperlipidemia [155,
157-160]. These data suggest that dietary activation of PPARα, for example through
supplementation with fatty acids that preferentially bind and activate this member of the
PPAR family [161], may be a means to attenuate fat deposition in commercial broilers.
Such action may underlie the reduced abdominal fat mass reported in broilers that were
fed diets rich in n-3 PUFA[162].

Both fasting and insulin neutralization elicited marked upregulation of PDK4.
PDK4 is a nutrient sensing fuel switch that phosphorylates and inactivates pyruvate
dehydrogenase, which shifts fuel use from glucose to fatty acids and spares glucose for
the brain during periods of fasting [143, 163-165]. PDK4 also enhances glycerol
synthesis in white adipose tissue by shunting pyruvate into glyceroneogenesis, at least in
the fed state [166]. Hepatic and skeletal muscle expression of PDK4 is increased by fatty
acids, acetyl CoA, NADH and the diabetic state and decreased by insulin and pyruvate
(rev. in [143, 167]). Little is known about PDK4 in chicken, but a recent study suggests it
acts as a glycogen sensor in muscle and thus plays comparable roles to those in mammals
[168]. In mouse white adipose tissue, PDK4 expression was shown to be induced by
activation of p38MAPK [169], which we found to be significantly up-regulated with
fasting and, to a lesser extent, with insulin neutralization [132]. Although PDK4 was upregulated in both treatment groups, and both groups showed evidence of increased
lipolysis [58], only fasted chickens presented a gene expression signature and tissue beta-
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hydroxybutyrate levels that were clearly indicative of fatty acid oxidation. Although we
did not measure malonyl-CoA levels, we predict that they were reduced with fasting, but
not insulin neutralization, based on reduced expression of ACACA. Malonyl-CoA
allosterically binds and inhibits CPT1A, minimizing fatty acid transport and subsequent
oxidation in mitochondria [170]. With insulin neutralization, increased PDK4 may thus
be more aligned with the demand for glycerol needed to reesterify fatty acids liberated by
lipolysis [166]. Additional experiments are needed to confirm that manipulation of PDK4
alters fatty acid oxidation in chicken adipose tissue and to delineate its relative
contributions to fatty acid oxidation and glyceroneogenesis under varying metabolic
states. If manipulation of PDK4 does alter fatty acid oxidation, our results highlight this
pathway as a potential target for reducing fatness, which has relevance for both poultry
and humans.

Microarray data indicate that the effects of fasting in chicken adipose tissue
extend beyond metabolism. GO analysis highlighted pathways such as cell cycle and
cytokine-cytokine receptor interaction that are most likely related to changes in the
stromal vascular fraction, which contains proliferating preadipocytes and cells of the
immune system. In particular, a number of genes that regulate multiple steps in
adipogenesis were significantly altered by fasting. Chickens rapidly accumulate
abdominal fat after hatch, and until approximately 7 weeks of age this is due more to
formation of new adipocytes than to adipocyte hypertrophy [127]. Adipocytes arise from
mesenchymal stem cells in a two stage process of lineage commitment to an adipocyte
fate, followed by differentiation of fibroblast-like preadipocytes into mature fat-storing
cells [171]. Members of both the Wnt (MSC lineage commitment) and TGFβ/BMP (MSC
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lineage commitment and preadipocyte competence) signaling pathways were
significantly regulated by fasting. Fasting down-regulated expression of CEBPα and
PPARγ, two transcription factors that orchestrate the cascade of gene expression changes
that lead to terminal adipocyte differentiation [171]. Expression of other adipogenic
mediators including fibroblast growth factor 2 (FGF2), fibroblast growth factor receptor 1
(FGFR1) [172], and nuclear receptor corepressor 1 (NCOR1) [173] were also
significantly regulated by fasting. Collectively, these changes suggest that adipocyte
number in chickens is dynamically tied to energy status, at least in young chicks (such as
those used herein) that are rapidly forming new adipocytes. An elegant study by Arner et
al. concluded that adipocyte number in humans is a major determinant of adult fat mass
and is determined during early childhood [174]. Less is known about this process in
humans due to the limitations of sampling adipose tissue, particularly during
development and from different abdominal depots. In light of what appears to be
sensitive regulation of adipogenesis by nutritional state, chickens may thus be particularly
valuable models in which to elucidate mechanisms of adipocyte hyperplasia during
development that would inform the study of human obesity.

It is worth noting that, despite the uncertainty about insulin signaling in chicken
adipose tissue, fasting altered the expression of several messengers encoding elements of
the insulin signaling cascade. Expression of PIK3CB, which encodes the catalytic p110
subunit of PI3K, was up-regulated with fasting, while PIK3R1, which encodes the
regulatory p85 subunit, was down-regulated. Such regulation could maintain some insulin
signals despite a fall in plasma insulin level. CBLB and CRK, which mediate insulin
signals that are associated with lipid rafts [175], were also up-regulated with fasting. In
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mammals, this pathway stimulates glucose uptake independently of PI3K activation,
which may shed light on the apparent refractoriness of PI3K activity to insulin that was
described in chicken skeletal muscle [58]. Therefore, the potential effects of insulin on
lipid storage and energy utilization appear to be defended in the fasting state, when
insulin levels fall, by enhanced insulin sensitivity at the post-receptor level. Additional
studies are needed to confirm this effect and to further explore the potential of PI3Kindependent effects of insulin on glucose utilization in chicken adipose tissue.

Insulin is not considered to be a key regulator of glucose metabolism in chicken
adipose tissue, although it does induce glucose disposal in chicken liver and muscle [62].
It is therefore not surprising that the majority of genes significantly altered by both
insulin neutralization and fasting are not related to glucose metabolism and lipid
synthesis. The main exception is DGAT2, which catalyzes the final step in esterification
of fatty acids into triglycerides. In fact, DGAT2 showed the most extreme downregulation (6.1- and 10.5-fold, insulin-neutralized and fasted, respectively) in each
treatment group, which is surprising considering that other genes related to lipogenesis
were only regulated by fasting. Suppression of DGAT2 expression may be due to
feedback by lipolysis, which appeared to be increased in both treatment groups based on
plasma NEFA levels. In general, our data indicate that insulin deprivation altered fatty
acid and glucose metabolism in a manner comparable to fasting but to a lesser extent,
such that most genes involved in these pathways did not exhibit statistically significant
changes in expression. For example, cluster analysis (Figure 3-2) revealed that some
genes upregulated by fasting were also increased by insulin neutralization (clusters 1, 3
and 4); these three clusters were enriched with genes in the KEGG pathways for fatty
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acid metabolism and PPAR signaling, including both ACOX1 and CPT1A, among others.
Similarly, among genes that were downregulated by fasting, clustering discriminated a
set of genes (Figure 3-2, cluster 2) with a trend to also be decreased (albeit to a lesser
extent than in fasting) by insulin deprivation. Interestingly, this cluster was significantly
enriched in functions related to carbohydrate metabolism, suggesting that insulin does
play some role in chicken adipose glucose metabolism. Comparable trends appeared in
the metabolomic data. For example, stearate and palmitate (the only fatty acids measured
by our MS platform) were lower (although not significantly) in both fasted and insulin
neutralized compared to fed birds (Additional file 3). While the purpose of our study
design was to determine the specific effects of insulin on chicken adipose tissue, we
cannot exclude the possibility that some of the overlapping changes in gene expression
were secondary to systemic factors, such as hyperglucagonemia present in both treatment
groups [58]. In vitro experiments using primary adipocytes or adipose explants will be
useful to confirm specific effects of insulin on genes identified herein.

Of the 13 changes in expression that were unique to insulin neutralization, the
most interesting responses were up-regulation of GCG, which encodes preproglucagon
(fold change = 2.91), and down-regulation of the glucagon receptor (LOC425670, fold
change = −2.77). The proglucagon system in avians is more complex than in mammals.
The avian preproglucagon locus encodes two distinct precursor proteins that yield
different peptides through alternative posttranslational processing: the class A transcript
(PGA) yields glucagon and glucagon-like peptide-1 (GLP-1), while the class B transcript
(PGB) additionally produces glucagon-like peptide-2 (GLP-2) and is more like the
mammalian transcript (rev. in [176]). Adipose tissue expresses both transcripts, with
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PGA being slightly more abundant, and is the third highest preproglucagon expressing
tissue in chicken, behind pancreas and the proventriculus [177]. We used transcriptspecific QPCR to determine that only the PGB transcript was up-regulated by insulin
neutralization (data not shown). Additional experiments are necessary to delineate which
of the encoded peptides are up-regulated in parallel, but the coincident down-regulation
of the glucagon receptor suggests a paracrine glucagon axis in chicken adipose tissue, and
one that is regulated by insulin. In support of this concept, plasma glucagon (presumably
derived largely from pancreas) was elevated comparably in both treatment groups [58],
while GCG expression in adipose tissue was only up-regulated by insulin neutralization.

Tissue metabolomic analysis highlighted effects of insulin neutralization that
were divergent from fasting and not readily apparent from microarray data. Most of the
tissue amino acids that were measured were higher with insulin-neutralization but lower
with fasting when each group was compared to ad libitum fed controls. This pattern
parallels the levels of αNH2NPN levels in blood [58]. Low levels in fasted adipose tissue
were most likely due to oxidation of the carbon skeletons for cellular energy through the
tricarboxylic acid cycle (TCA) cycle and/or for glyceroneogenesis, in the absence of
dietary glucose. Increased amino acid catabolism was reflected in the differential
expression profiles of the fasted vs. fed comparison (Figure 2-3; Additional file 1). In the
insulin neutralized group, however, glucose supply from food was maintained and
preferentially oxidized for energy. Elevated amino acids in the insulin neutralized group
may also reflect reduced utilization due to the lack of insulin’s anabolic effects,
particularly on the proliferating cell population within adipose tissue. The metabolomics
approach used here measured only metabolite pool sizes at the time that tissues were
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harvested, rather than the effect of fasting or insulin neutralization on the rates of
metabolism through glycolysis and the TCA cycle. The latter would be much more
informative with respect to the dynamic impact of treatment, but requires the use of
isotopic labeling (e.g., by feeding 13C-labelled glucose) which was not performed in this
study. Nonetheless, we were able to demonstrate significant effects on some metabolites
that inform the parallel changes in gene expression, particularly in relation to amino acid
metabolism. Combined clustering of metabolomic and gene expression together
identified a set of genes correlated with many amino acid levels, including PIK3R1, ME
and MCD.

Conclusions
In summary, we determined that adipose tissue metabolism in the chicken is
regulated by energy status and, to a lesser extent by insulin. Although adipose tissue is
not a primary site of lipogenesis in chicken, the rate-limiting genes for fatty acid
synthesis were suppressed by fasting. Likewise, fasting appeared to increase aspects of
insulin sensitivity based on expression profiles, despite the view that chicken adipose
tissue is relatively insensitive to insulin. Consistent with this paradigm, insulin
neutralization significantly altered the expression of only a few genes related to glucose
and lipid metabolism. Nonetheless, a considerable number of genes were altered by
insulin neutralization, many of which thus far have unclear roles in adipose biology.
Expression profiles suggest that even short term fasting alters fat storage in broilers by
enhancing the oxidation of fatty acids. The initiating events that trigger upregulation of
the corresponding genes are unclear, but there is considerable evidence for activation of
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PPARa, LXRa, and potentially other transcription factors that are activated by fatty acid
ligands. Further studies are warranted to identify these triggers because of their potential
impact on fat storage. Our data also suggest that broiler chicks may be an informative
model organism in which to investigate dietary effects on adipose development in light of
what appears to be a relationship between energy intake and adipogenesis. The results of
this study thus have dual benefit for both the poultry industry and for studies of obesity in
humans.
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Figure 2-3 KEGG pathway analysis of genes differentially expressed in fasting vs.
fed. Genes differentially expressed in fasting vs. fed were matched to KEGG pathway
membership using ClueGO. The percentage and #genes/term indicates the percentage and
number of the genes in the pathway that are contained in the set of genes altered by
fasting. • p < 0.1 * p < 0.05 **, p < 0.01, based on Benjamini-corrected p-value
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Figure 2-4 Heat map of metabolites. The median value of each metabolite in each
treatment group was used to calculate fold-change of fasted vs. fed, insulin-neutralized
(insneut) vs. fed, and insulin-neutralized vs. fasted, and then values were subjected to
hierarchical clustering.
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CHAPTER III
GENETIC LEANNESS IN DOMESTIC CHICKENS IS
ASSOCIATED WITH INCREASED FATTY ACID
OXIDATION IN WHITE ADIPOSE TISSUE
This manuscript will be submitted to Physiological Genomics with the following author
list:
Bo Ji, Jesse L. Middleton, Ben Ernest, Arnold M. Saxton, Susan J. Lamont, Shawn R.
Campagna and Brynn H. Voy

Introduction
Domestic chicken has been intensively studied because of its role as an efficient
source of lean meat. However, commercial broilers resulting from genetic selection for
rapid growth demonstrate detrimental traits, such as excess deposition of abdominal
adipose tissue, metabolic disorders, and reduced reproduction [178]. Of interest, such
traits are also associated with human obesity [179]. Therefore, fast-growing broilers
(meat-type) represent “obese” chickens compared to slow-growing egg layers (e.g,
Leghorn) or wild-type strain chickens (e.g., Fayoumi) (rev. in [120]). Fayoumi chickens,
originating from Egypt, represent a hardier stain of chickens that is more resistant to
diseases [180]. Fayoumi has fast maturity and lays small eggs, which makes it a layer
mostly raised in farms. Leghorn chickens are the original breed of commercial U.S
layers. Both lines were maintained highly inbred by Iowa State University poultry
geneticists with an inbreeding coefficient higher than 0.95. Both Fayoumi and Leghorn
demonstrated lean phenotype compared to broilers, and these three lines of chickens are
genetically distant from each other [181]. Specifically, chicken F2 populations generated
from commercial broilers male line and two genetically distinct inbred lines (Leghorn
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and Fayoumi) provide unique models through which to integrate phenotypes with
genotypes. Genome-wide linkage analyses on F2 populations have identified QTLs
associated with abdominal fat percentage [182], skeletal integrity, and metabolic traits in
the chickens [111-114]. However, the genomic characterization of adipose tissue from
the parental lines has not been studied yet.
Additionally, study of egg-laying chickens provides insights to understand lipid
mobilization, transfer and utilization for yolk precursor synthesis, which is important in
deposition of yolk and embryo development [183].

Chickens also possess unique

features, including natural hyperglycemia (up to 200 mg/dL in the fasting state) and
resistance to exogenous insulin [121, 122], which mimic early stage of type 2 diabetes in
humans. Most of the genes located the quantitative trait loci (QTLs) regions for the
fatness trait were found to be obesity and diabetes related genes in humans [115-117].
Unlike rodents, de novo lipogenesis in adipose tissue is relatively low in chickens and
humans [123-125], which implicate the similarity of adipose metabolism between
chickens and humans. Likewise, adipose cellular development is characterized by
hyperplasia early in life through posthatching to first several weeks of age [78], and it
paralleled hypertrophy through adulthood, and predominant hypertrophy at an older age.
This correlates with the observations in humans that adult-onset obesity is associated with
increased adipocyte size, whereas early-onset obesity has both adipocyte hypertrophy and
hyperplasia [80].
Previously, we identified pathways related to adipose metabolism, signaling and
adipogenesis by characterizing the response of chicken adipose tissue to short-term feed
restriction, which is a management practice in broiler industry to control fatness [184]. In
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the present study, we assessed the physiological, transcriptomic and metabolomics
variations on adipose tissue of three genetically distinct lines of chickens: Fayoumi (M
5.1), Leghorn (Ghs-13) and commercial broilers. We aimed to 1) understand the adipose
physiology of genetically distinct lines of chickens; 2) identify genes and pathways
associated with the leanness of wild chickens, which are potential targets for control of
fatness in broilers through either genetic selection or improved management practices.
Plasma metabolites and endocrine parameters were investigated and abdominal adipose
tissue transcriptomics and metabolomics were assayed by microarrays and LC-MS. The
association of gene expression, metabolic and physiological responses was performed to
provide a comprehensive understanding of the variation in fatness between broiler,
Fayoumi and Leghorn.

Methods and Materials
Animals
Male birds from broiler, Leghorn (Ghs-13) and Fayoumi (M5.1) lines maintained
at the Iowa State University were sacrificed at week 7 by our collaborator in Dr.
Lamont’s lab who provided tissue samples. All hatched chicks ( inbred Leghorn, inbred
Fayoumi, and broilers) were wing-banded for individual pedigree identification. Birds
were grown under standard management conditions from hatch to 7 weeks of age and had
ad libitum access to water and feed.
Determination of physiological parameters
Body weight and fat weight were measured at week 7. Abdominal adipose tissue
and serum samples from six birds of each line were collected and rapidly snap-frozen in
liquid nitrogen, then stored at -80oC until analysis. Serum glucose levels were measured
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by the glucose oxidase method using glucose colorimetric kit (Cayman, MI, USA). Free
or non-esterified fatty acid (NEFA) levels and triglyceride (TAG) were determined using
an enzymatic colorimetric kit (Wako Chemicals, Neuss, Germany). Glucagon and VLDL
levels in the serum were determined by chicken glucagon ELISA kit and chicken VLDL
ELISA kit (Novatein Biosciences, MA, USA). ß-hydroxybutyrate (b-HB) was determined
by enzymatic colorimetric kit (Biovision, CA, USA). Lipid peroxidation was determined
by measuring thiobarbituric acid reactive substrates (TBARS) (Cayman, MI, USA).
Histological analysis of adipocyte size
A portion of the abdominal fat pad was fixed in 4% paraformaldehyde then
washed in PBS. The samples were embedded in paraffin, cut into 5μm sections, and
stained with hematoxylin and eosin. Adipocyte size was measured using a previously
established method [185]. Briefly, the tissue sections were viewed at 10X magnification,
and images were obtained. The illumination of the images was adjusted using
CellProfiler cell image analysis software (www.cellprofiler.org). After the illumination
was adjusted, the images were converted to a binary image in ImageJ (NIH;
rsbweb.nih.gov/ij/) using the following commands: Gray Mode and Threshold. The
binary images were further adjusted using Despeckle, Watershed, Erode, and Paintbrush.
The cross-sectional area of the adipocytes was measured using the “Analyze particles”
command. Approximately 200 adipocytes per chicken were measured.
Gene expression
Total RNA was isolated from chicken adipose samples using the RNeasy Lipid kit
and incorporating an on-column DNase treated with the RNase-free DNase Set according
to the manufacturer's protocol. RNA quality and concentration was measured using the
Experion System (BioRad.com); only RNA passing recommended standards of quality
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was used for further studies. Transcriptome profiling in chicken adipose tissue was
performed by Genome Science Resource at Vanderbuilt University (Nashville, US) using
the Affymetrix GenChip chicken genome array on the Affymetrix platform (San Diego,
CA). For real time PCR validation, cDNA was synthesized using the iScript cDNA
Synthesis kit. Commercially designed and validated primer sets (QuantiTect) primers
were used in conjunction with the QuantiTect SYBR Green PCR kit on a CFX96 realtime PCR detection system (Bio-Rad.com). RNA isolation and quantitative PCR (QPCR)
reagents were obtained from Qiagen (qiagen.com). All samples were analyzed in
triplicate and normalized to ß-tubulin. Relative differences in gene expression were
determined using the ΔΔCT method (2-ΔΔCT as the fold change) and statistical differences
were tested by analysis of variance (ANOVA) [134].
Liquid chromatography coupled with tandem mass spectrometry (LCMS/MS)
Abdominal adipose tissue samples from six birds of each line (the same six birds
used for expression profiling) were extracted by placing tissue in a mortar containing
liquid nitrogen and then powdering with a pestle. Portions (8 - 40 mg) of the powered
tissue were weighed into 1.5 mL centrifuge tubes. Chilled methanol (0.3 mL at -80 oC)
and internal standard (5 µL of 1.7 mM benzoic acid in negative mode or 4.25 mM tris
(hydroxymethyl) aminomethane in positive mode) were added to each tube. Each tube
was mixed thoroughly by vortexing for two minutes, and the metabolites were extracted
from the tissue for 30 min at 4 oC. The tubes were then centrifuged (5 min, 4 oC, 16.1 rcf)
and supernatant was removed. The extraction procedure was repeated for three times.
Supernatant was split into two autosampler vials. One of these samples was immediately
placed on the LC-MS/MS for analysis, while the other was stored at -80 oC for analysis in
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the opposite polarity ion mode on the following day. The samples were placed in an
autosampler tray chilled to 4 oC, and 10 µL of each was injected onto an LC column for
analysis as described previously.
Statistical analysis
Statistical analysis of the microarray data was performed using R 2.13.0 and
routines contained in Bioconductor (bioconductor.org) as described in previous study
[184]. Statistical analysis of metabolomic data was performed using an analysis tool that
we developed specifically for metabolomic data analyses [140]. The script (metabR),
written in the language R, uses linear mixed-effect modeling to normalize metabolomics
data for fat mass and internal standard . The script averages any replicate measurements
(statistical sampling) made on experimental units and performs ANOVA to test for
statistical differences between experimental groups. Body weight, fat weight, adipocity,
and plasma levels of glucose, triglyceride, NEFA and TBARs were compared among
groups using Tukey test in SAS 9.0. Distribution of adipocyte sizes was analyzed using
propTable and plotted in R 2.13.0.

Results
As expected, measures of fatness differ significantly between the three lines.
Broilers are significantly fatter than Fayoumi and Leghorn in terms of body weight, fat
weight, and adiposity (Table 3-1). The relationships between the physiological
parameters were demonstrated using Pearson correlation coefficient (Table 3-2).
Adipocyte size increased with fatness and differed significantly between each pairwise
comparison, with the largest fat cells found in broilers and the smallest in Leghorn, the
leanest of the three lines (Figure 3-1A). The number of very large adipocytes (>10000
um2) was about 8% in the tissue of broilers, but less than 1% in Fayoumi and Leghorn
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(Figure 3-1B). Plasma levels of non-esterified fatty acids (an index of lipolysis) and βhydroxybutyrate (a systemic measure of fatty acid oxidation) were significantly higher in
lean chickens, i.e., Leghorn and Fayoumi, than broilers (p <0.05). Circulating VLDL
levels were more than three times greater in broilers vs. Fayoumi, consistent with
elevated VLDL in genetically selected fat lines of chickens [23, 24]. However, plasma
level of VLDL in Leghorn was similar to broilers. Thiobarbituric acid reactive substances
(TBARs), byproducts of lipid peroxidation, were higher in Fayoumi and Leghorn than
broilers, but not statistically different. Plasma glucose and glucagon levels did not differ
significantly between the three lines of chickens (data not shown).
Physiological differences among the lean lines compared to broilers are paralleled
by significant differences in adipose gene expression profiles. Expression levels of a total
of 2361 genes were differentially expressed in Leghorn and/or Fayoumi compared to
broilers based on an FDR adjusted p-value < 0.05 (Additional file 1; Figure 3-2A).
Ninety-three percent (2212 of 2361) of these genes showed a fold-change > |1.5| (Figure
3-2B). The number of genes that were differentially expressed in Fayoumi vs. broiler and
Leghorn vs. broiler are essentially equivalent (1179 and 1354 genes, respectively).
Eleven genes of interest were selected based on fold-change or biological
functions of interest based on our prior fasting study (Figure 3-2). Differential expression
of PDK4, DUSP5, CCL20, TLR4, AGTR1 and NAMPT in Leghorn versus broilers was
identified. Genes that were differentially expressed in Leghorn compared to broilers were
also differentially expressed in Fayoumi except for AGTR1 based on real-time RT-PCR.
All of the genes confirmed by QPCR as increased in lean vs. fatty lines were previously
shown to be up-regulated in fasted vs. fed adipose tissue.
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Hierarchical cluster analysis of the 2361 genes that were differentially expressed
in at least one pairwise comparison was used to visualize the similarities and differences
between groups. As shown in Figure 3-4A, birds within each of the three genetic lines
clustered together. The dendrogram also shows that expression profiles in broiler adipose
tissue were distant from those of Fayoumi and Leghorn, which were more similar to each
other. Eight clusters representing different patterns were identified in terms of gene
expression (Figure 3-4B). Four clusters (1, 3, 4 and 7) were of interest because their
expression patterns qualitatively correlated with fatness (Figure 3-4). The genes in each
cluster were submitted to Gene Ontology analysis, which provides the biological
interpretation of the clusters and identifies significantly over-represented GO terms and
pathways (Table 3-3).
Cluster 1 contains genes expressed at higher levels in Fayoumi and Leghorn vs.
broiler. This set of genes was significantly enriched in endocytosis, regulation of Ras
protein signal transduction, fatty acid metabolic process and regulation of catabolic
process.

Cluster 7 contains genes of the inverse pattern, with lower expression in

Fayoumi and Leghorn compared to broiler. These genes are enriched in steroid
biosynthesis, oxidative phosphorylation and negative regulation of low-density
lipoprotein particle receptor biosynthetic process.
Cluster 3 consists of genes with the highest expression in broiler and the lowest
expression in Leghorn, corresponding to the two extremes in terms of degree of fatness.
These sets of genes were significantly enriched in functions related to lipid biosynthetic
process, cholesterol metabolic process and lipid metabolic process (Table 3-2). Contrary
to cluster 3, cluster 4 contained genes with highest expression in Leghorn and lowest in
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broilers. This set of genes represents a number of functional annotations, including
calcium ion transport and cellular calcium ion homeostasis.
GO enrichment was used to functionally annotate the set of 1233 genes that were
differentially expressed between broilers and Leghorns, the leaner of the two lean lines.
The biological process GO terms were used to characterize the genes differentially
expressed in Leghorn versus broilers based on FDR<0.05 and absolute fold-change ≥1.5
(Figure 3-5A). Leghorn differed from broilers in a diverse set of processes related to lipid
and fatty acid metabolism and synthesis. This set of processes includes fatty acid and
lipid biosynthetic processes, sterol and cholesterol biosynthetic and metabolic processes,
fatty acid oxidation, lipid modification, fat cell differentiation, carboxylic acid catabolic
process. Within these categories, the expression of genes involved in fatty acid oxidation
(e.g, acetyl-CoA carboxylase beta (ACACB), carnitine palmitoyltransferase 1A
(CPT1A), protein kinase, AMP-activated, alpha 1 catalytic subunit (PRKAA1)) were upregulated in Leghorn compared to broilers, while expression of genes that control fatty
acid, sterol, cholesterol and triacylglycerol synthesis were down-regulated (e.g.,
Diacylglycerol O-acyltransferase homolog 2 (DGAT2), 3-hydroxy-3-methylglutarylCoenzyme A reductase (HMGCR), stearoyl-CoA desaturase (SCD), farnesyl diphosphate
synthase (FDPS), and acetoacetyl-CoA synthetase (AACS), fatty acid desaturase 1 and 2
(FADS1 and FADS2 )). However, we also found that some genes in fatty acid oxidation
(ACAD11, ACOX2) were down-regulated in Leghorn. Leghorn also showed upregulated expression of genes related to the regulation of adipogenesis (e.g., lipin 1
(LPIN1), laminin alpha 4 (LAMA4), WNT inhibitory factor 1 (WIF1), transcription
factor 7-like 2 (TCF7L2), tribbles homolog 2 (TRIB2), frizzled-related protein (FRZB),
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aldehyde dehydrogenase 6 family (ALDH6A1)). Leghorn also had a lower expression of
genes involved in antigen processing and presentation (e.g., major histocompatibility
complex (MHC) Rfp-Y class I alpha (YFVI), MHC class I antigen (YFV), MHC class II
antigen B-F minor heavy chain; MHC class II beta chain (BLB1), similar to MHC Rfp-Y
class I alpha

MHC I-related (MR1)). The diversity of MHC was identified to be

responsible for the genetic resistance to pathogens in chickens [186]. This is also
consistent with the previous findings that Leghorn line was the most susceptible to
pathogens [180].
Genes in many of the same pathways were also differentially expressed in
Fayoumi vs. broilers. Genes that differed between these two strains, based on FDR<0.05
and absolute fold-change ≥1.5, were significantly enriched in fatty acid and lipid
catabolic process, lipid modification, fatty acid oxidation, carboxylic acid catabolic
process (Figure 3-5B). Among these categories, the genes that were up-regulated are
involved in fatty acid oxidation (ACACB, ACAD11, ACOX2, EHHADH, PHYH,
PRKAA1).
Metabolic intermediates that were significantly altered in Leghorn and Fayoumi
compared to broilers were identified. A total of 92 metabolites were detected based on
spectral peak area (in ion counts) (Table 3-5). A total of 47 metabolites were different
between treatment groups based on adjusted p<0.05. Metabolic intermediates of
glycolysis/gluconeogenesis

pathways,

including

phosphoenolpyruvate

and

3-

phosphoglycerate, were significantly higher only in Leghorn vs. broilers (p<0.05),
although the levels of glucose-6-phosphate, glycerol-3-phosphate and pyruvate were
similar in Leghorn chickens vs. broilers. The accumulation of phosphoenolpyruvate and
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3-phosphoglycerate may reflect the decrease in glycolysis or increase in gluconeogenesis
in Leghorn chickens.
Some metabolic intermediates (carnitine, acetylcarnitine, pentose phosphate,
glycerophosphocholine, and UDP-N-acetylglucosamine (GlcNAC)) involved in lipid and
carbohydrate metabolism were significantly higher in both Fayoumi and Leghorn, as
compared to broilers. In contrast to Leghorn, tissue levels of amino acids were higher in
Fayoumi vs. broilers, with statistically significant increase of threonine, proline, valine
and ornithine. It is worth noting that NADPH, the reducing agent in lipid biosynthesis,
was significantly decreased in Fayoumi vs. broilers (p<0.05). Only 11 metabolites were
significantly different in Fayoumi and Leghorn. Five metabolites (threonine, pantothenate,
pyruvate, aspartate, and ox._Glutahion) were lower in Leghorn vs. Fayoumi, but the
others

(asparagine,

1-Methylhistidine,

NADPH,

Ethanolamine_or_Urea,

Hypoxanthine_(NEG), 3-Phosphoglycerate) were higher in Leghorn.

Discussion
Although attention has been drawn to domestic chickens because of their role as
an important food animal, few studies have examined the transcriptomic and
metabolomics differences of adipose tissue between different strains of chickens,
specifically, egg-laying, meat-type chickens, and broilers. The primary objective of our
present study was to define the transcriptomic and metabolomic characterization of
distinct genetic lines of chickens that present different phenotypic traits to further
understand adipose biology in domestic chickens. Secondly, we aimed to identify the
association of genomic responses in adipose tissue with physiological and metabolic
responses in chicken to solidify the status of chicken as a model organism for studies of
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human obesity. We expected that the differences in gene expression and metabolites of
three lines of chickens might explain the distinct phenotypic differences in the fatness of
broilers and wild chickens.
The lean phenotypes of Fayoumi and Leghorn were regulated by genes involved
in various pathways and biological processes related to lipid and fatty acid biosynthesis
and metabolism (Figure 3-6). Lipid accumulation in adipose tissue of chicken was
considered partially through uptake of lipoproteins assembled in liver [41]. The candidate
receptors responsible for lipid accumulation in adipose tissue include LDL receptor
(LDLR), VLDL receptor (VLDLR) and LDL receptor-related protein (LRP) [187]. Our
data demonstrated that the expression of LDLR and VLDLR were down-regulated in
Leghorn vs. broiler. Apolipoprotein A1 (APOA1), a major protein component of high
density lipoprotein (HDL) [36], was found to be significantly up-regulated in Leghorn.
And LRP and VLDLR were down- regulated in Fayoumi. These results indicated there
might be lower uptake of VLDL-triglycerides in adipose tissue of lean chickens
compared to broilers. VLDL and vitellogenin (VTG) are major yolk precursors. Egglaying hens exhibit high plasma levels of VLDL and VTG at the onset of egg laying
[188]. Therefore, the down-regulated VLDL receptor in adipose tissue of egg-type
chickens was probably to accumulate VLDL in plasma.
Genes differentially expressed in adipose tissue of Leghorn in this study
overlapped with those altered by 5 hour fasting in adipose tissue of broilers, including
genes enriched in lipids and cholesterol biosynthesis and fatty acid oxidation pathways
[20]. The genes enriched in lipid biosynthetic process were down-regulated, but in fatty
acid oxidation were up-regulated in white adipose tissue of Leghorn compared to broilers.
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Acetoacetyl-CoA synthetase (AACS) was down-regulated (2.1- fold) in Leghorn vs.
broiler. AACS catalyzes the formation of acetoacetyl CoA, which is the precursor of
HMG-CoA, initializing cholesterol synthesis. Additionally, a number of genes (ACAT2,
FDPS, IDL1, SQLE, LSS, SC4MOL, NSDHL, HSD17B7, DHCR7, DHCR24) involved
in the whole mevalonate pathway were significantly down-regulated in Leghorn vs.
broiler. Diacylglycerol kinase, theta (DGKQ) was down regulated (4.3-fold) in Leghorn
vs. broiler. DGKQ is a member of diacylglycerol kinases family that metabolize
1,2,diacylglycerol (DAG) to produce phosphatidic acid (PA). Together with the down
regulation of DGAT2 and elevated tissue level of glycerolphosphocholine, our results
indicate that the energy consumed may contribute to the synthesis of phosphatidylcholine
by increasing glycerolphosphocholine instead of TAG or PA in adipose tissue of Leghorn.
Interestingly, we found PDK4, one of the most markedly up-regulated genes by 5
hour fasting in adipose tissue of chicken, was greatly up-regulated (5.5- fold) in Leghorn
vs. broiler. PDK4 phosphorylates and inactivates pyruvate dehydrogenase, functioning as
the fuel switch that shifts fuel use from glucose to fatty acids during fasting. PDK4 may
also contribute to glyceroneogenesis or gluconeogenesis by shunting pyruvate for
glycerol synthesis or enhancing substrate for gluconeogenesis [189, 190]. Increased tissue
levels of phosphenolpyruvate and phosphoglycerate, intermediates of glyceroneogenesis
and gluconeogenesis pathways, confirmed this concept. Thus, upregulation of PDK4 in
both lean chickens and fasted chickens indicate that PDK4 could be a potential target to
manipulate for reducing fatness in chickens. Expression of other genes related to fatty
acid oxidation, such as lipin-1 and CPT1A, were significantly up-regulated in Leghorn vs.
broilers based on fold-change. Lipin-1 was recently shown to amplify PPARα and Pgc-1α
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activity, further enhancing fatty acid oxidation in liver [191]. Additionally, elevation of
tissue levels of carnitine and acetylcarnitine in lean chickens further confirmed increased
fatty acid oxidation. Carnitine and acetylcarnitine, the activated form of carnitine, play an
important role in fatty acid oxidation by transporting long-chain acyl groups from fatty
acids into the mitochondrial matrix. This process is accomplished by the carnitine
palmitoyltransferase (CPT) system. CPT1A is rate-limiting enzyme initiating the
mitochondrial oxidation of long-chain fatty acids. Consistent with upregulation of genes
and metabolites in fatty acid oxidation, we also found elevations in plasma NEFA and Bhydroxybutyrate, which suggested elevated lipolysis and fatty acid oxidation in lean
chickens.
In addition to fatty acid metabolism, the cluster of genes enriched in calcium ion
transport and cellular calcium ion homeostasis represent the unique characterization of
Leghorn as a layer line. Differential expression of this set of genes may result from the
selection on higher egg and eggshell weight in layers, which require high amounts of
calcium for the formation of eggshells [192].
In contrast to Leghorn, genes (HIBCH, ALDH2, ALDH3A2, ALDH6A1,
EHHADH, MCD, MUT, SUCLG2) enriched in functions related to propionate
metabolism were up-regulated in Fayoumi vs. broilers. Enoyl-CoA, hydratase/3hydroxyacyl CoA dehydrogenase (EHHADH), which is an L-bifunctional enzyme
involved in classical peroxisomal fatty acid β-oxidation pathway, was recently
recognized as indispensable enzyme for the production of medium-chain dicarboxylic
acids [193]. Malonyl-CoA decarboxylase (MCD), the enzyme responsible for
decarboxylation of malonyl-CoA to acetyl-CoA, was significantly up regulated (3.78-fold)
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in Fayoumi. Increased MCD activity resulted in an elevated rate of fatty acid oxidation in
liver and heart by rapidly decreasing malonyl –CoA level [194-196]. Methylmalonyl
CoA mutase (MUT) and succinate-CoA ligase (SUCLG2) are responsible for conversion
of propanoyl-CoA (a product of beta-oxidation of odd-chain fatty acids or BCAA) to
succinyl-CoA for energy [197]. Similarly, Hydroxyisobutyryl-CoA Hydrolase (HIBCH)
catalyzes the pathway for the metabolism of branched-chain amino acid (BCAA) and
propionate, indicating the increased proteolysis to provide energy. A recent study
demonstrated that SUCLG2 and HIBCH were up regulated in the lipodystrophic mice
model [198]. Aldehyde dehydrogenases (ALDHs), a superfamily of NAD(P)(+)dependent enzymes with similar primary structures, catalyze the oxidation of a wide
spectrum of endogenous and exogenous aliphatic and aromatic aldehydes to fatty acids
[199]. Three genes (ALDH2, ALDH3A2, ALDH6A1) encoding enzymes of ALDHs
family were up-regulated in Fayoumi. Aldehyde dehydrogenase enzymes produce
NADPH, which is consistent with higher levels of NADPH in Fayoumi vs. broilers. The
substrates of ALDHs are the products of lipid peroxidation, therefore elevated ALDHs
may be due to higher lipid peroxidation, which was confirmed by higher serum TBAR
level in Fayoumi chickens. However, some of these genes (EHHADH, MCD, HIBCH,
and ALDH2) were down-regulated in Leghorn, as compared to broilers. The distinct
regulation of the same genes in propionate metabolism pathway in Fayoumi and Leghorn
reflected their preference for energy sources. Leghorn mainly utilized energy from
oxidation of long chain fatty acids instead of oxidation of carbohydrate, whereas
Fayoumi consumed energy from oxidation of medium chain fatty acids and/ or
metabolism of amino acids from elevated proteolysis.
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Gene expression profiling of adipose tissue indicated that the features that
distinguished the three lines of chickens from each other are not limited to metabolism. In
particular, GO analysis demonstrated that genes were enriched in fat cell differentiation
pathway in Leghorn. Mesenchymal stem cells (MSC) give rise to adipocytes by lineage
commitment, preadipocytes proliferation, and differentiation. CEBPa, the transcription
factor that triggers the adipocyte differentiation, was significantly down-regulated in
Leghorn vs. broiler. However, adipose differentiation-related protein (ADFP) was
significantly up-regulated in Leghorn. ADFP is specific marker for lipid accumulation,
whereas, it was also found to be induced by long chain fatty acid, PPARa and fasting in
liver [200, 201]. The expression of adipogenic mediators, including fibroblast growth
factor 2 (FGF2) and fibroblast growth factor receptor 3 (FGFR3), was significantly
down-regulated in Leghorn compared with broilers. Additionally, the substantial upregulation of Wnt inhibitory factor 1 (WIF1, 44.8-fold) in Leghorn vs. broiler indicates
the inhibition of Wnt (MSC lineage commitment) signaling in Leghorn [202]. In contrast,
these genes ((WIF1), adiponectin (ADIPOQ), and chibby (CBY1) ) were down-regulated
in Fayoumi [203]. In agreement with data of adipocyte sizes, Leghorn showed dramatic
changes of genes in the development of adipocytes, while the changes in Fayoumi were
minimal. It worth noting that transcription factor 7-like 2 (TCF7L2) was significantly
differentially expressed in both Leghorn and Fayoumi vs. broilers. TCF7L2 was found to
be associated with type 2 diabetes in adults and impaired glucose metabolism in children
[204]. This implicates the potential application of chicken as a model to study human
obesity and diabetes.
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Leghorn and Fayoumi demonstrated different expression of genes related to
insulin signaling cascades. Expression of inositol hexakisphosphate kinase (IP6K2) was
up-regulated in Leghorn vs. broilers. Expression of PIK3CB and PIK3C2A, which
encode isoforms of class I and class II of PI3Ks respectively [205], were up-regulated in
Fayoumi vs. broilers. Expression of PRKAA1 and PRKAB2, which encode catalytic and
regulatory subunits of the 5 prime AMP-activated protein kinase (AMPK), were upregulated (21- and 2- fold, respectively) in Fayoumi vs. broilers, whereas only PRKAA1
was up-regulated in Leghorn. AMPK plays a major role in ACC and MCD regulation by
phosphorylating and inactivating ACC activity, but activating MCD activity, which
favors fatty acid oxidation [206].

Thus, the marked increase of PRKAA1 may be

responsible for the transcriptional alteration of genes in fatty acid oxidation in lean
chickens.

A recent study found activation of AMPK inhibits PPARa and PPARy

transcriptional activity in hepatoma cells [207], which may result in insignificant changes
of PPARa and PPARy in lean chickens.
In summary, we determined that adipose tissue metabolism in lean chickens is
distinct from that in broilers. The leanness of Leghorn (layer) and Fayoumi (meat type)
were regulated by various pathways related to lipid and fatty acid biosynthesis and
adipogenesis. Expression profiles indicated that fatty acid metabolism was altered from
storage toward oxidation in lean chickens. Our data also suggest the differences in
adipose metabolism between layers and meat type chickens. This study is beneficial to
both obesity study and poultry science.
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Table 3-1. Physiological parameters of three lines of chickens.

body weight (g)
fat weight (g)
Fat/BW
non-esterified fatty acid (mM)
triglyceride (mg/dL)
ß-hydroxybutyrate (mM)
TBARS (uM)
very low density lipoprotein
(ug/ml)
glucagon (pg/ml)

Broiler
Fayoumi
Leghorn
a
b
2208.2±214.1
524.1±35.5
415.19±18.2 b
20.0±5.6a
3.3±1.8b
1.5±0.8b
a
b
0.009±0.0002 0.006±0.0002 0.004±0.00018c
0.21±0.03c
0.41±0.07a
0.29±0.04b
57.99±14.8b
98.96±32.3a
56.55±25.6b
0.34±0.05c
0.57±0.07a
0.44±0.05b
a
a
2.2±0.7
3.1±1
2.6±0.7a
0.085±0.027a 0.024±0.0025b 0.070±0.019a
76.7±11.6a
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82.6±20.2a

84.1±5.5a

Table 3-2 Correlation of physiological parameters
Variable
by Variable
Correlation
adiposity
fat weight
0.58
Triglyceride
0.73
ß-hydroxybutyrate
body weight
-0.69
ß-hydroxybutyrate
fat weight
-0.63
ß-hydroxybutyrate
fat weight
body weight
0.94
NEFA
adiposity
-0.73
NEFA
fat weight
-0.57
0.53
TBARS
ß-hydroxybutyrate
VLDL
-0.63
TBARS
VLDL
fat weight
0.62
VLDL
body weight
0.56
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p-value
0.02278
0.00187
0.00406
0.01263
1.1E-07
0.00188
0.02712
0.04326
0.01126
0.01324
0.02868

Table 3-3. Gene ontology (GO) and KEGG annotation for representative clusters of
differentially expressed genes.
Cluster

1
(180
genes)

Annotat
ion

KEGG

GO

GO term (Biological
process, level of 6 or 7)
or KEGG pathway
name

FDR
p-value

Genes

Ribosome biogenesis in
eukaryotes

9.7 E-3

[HEATR1, REXO1, SBDS,
TBL3]

Melanogenesis

1.2 E-2

Endocytosis

3.8 E-2

ncRNA metabolic
3.9 E-2
process
Regulation of Ras protein
4.2 E-2
signal transduction
Fatty acid metabolic

2
(260
genes)

GO

KEGG
3 (439
genes

KEGG

Regulation of small
GTPase mediated signal
transduction
Regulation of catabolic
process
Regulation of sequencespecific DNA binding
transcription factor
activity

4.4 E-2
4.6 E-2

[ARFGEF1, FGD3, FGD4,
GIT2, GPR65]

5.0 E-2

[ADRA1B, GIT2, GPR65,
PRKAA1, UVRAG]

2.0 E-2

[FZD4, HCK, ID2, PRKCH,
VEGFA]

Peptidyl-amino acid
modification

2.1 E-2

Brain development

3.8 E-2

Peptidyl-tyrosine
phosphorylation
Peptidyl-tyrosine
modification
Regulation of
neurogenesis
Ribonucleotide metabolic
process
Phagosome
Terpenoid backbone
Biosynthesis
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[CREB3L2, FZD6, MITF,
TCF7L2]
[BF2, GIT2, RAB22A,
VPS4B]
[INTS2, INTS6, SBDS,
TBL3]
[ARFGEF1, FGD3, FGD4,
GIT2, GPR65]
[ACACB, HPGD, LPIN1,
PRKAA1]

4.3 E-2
4.3 E-2
4.5 E-2
4.6 E-2
1.9 E-2
2.6 E-4

[ADH5, CD3E, CSRP2BP,
HCK, PDK3, PRMT7,
VEGFA, WEE1]
[FZD4, GPR56, ID2, NPY,
SLC4A7, ULK1]
[CD3E, HCK, VEGFA,
WEE1]
[CD3E, HCK, VEGFA,
WEE1]
[DLL1, ID2, PRKCH,
ULK1, VEGFA]
[ATP1B1, GART, TMED2,
UMPS]
[ATP6V0A1, BLB2,
COMP, MARCO]
[ACAT2, FDPS, HMGCR,
IDI1, PDSS1]

Table 3-3 Continued
Cluster Annotat GO term (Biological
ion
process, level of 6 or 7)
or KEGG pathway
name

GO

FDR pvalue

Steroid biosynthesis

7.9 E-4

Metabolic pathways

3.2 E-3

Lipid biosynthetic
process
5.5 E-3

Cholesterol metabolic
process
Lipid metabolic process

8.8 E-3

2.9 E-2

Alcohol metabolic
process
4
(296
genes)

4.3 E-2

Genes
[DHCR7, LSS, NSDHL,
SC4MOL]
[ACAT2, ACLY, ACOX2,
ACSS3, AK2, ALDH2,
ALDH4A1, ALG11,
ATP6V0E1, DEGS1,
DGKQ, DHCR7, EXTL3,
FDFT1, FDPS, HMBS,
HMGCR, HPRT1, IDI1,
LSS, MMAB, NADSYN1,
NDUFA11, NDUFB2,
NSDHL, OXSM, PAPSS1,
PLA2G6, PLCD1, PRDX6,
QDPR, SC4MOL, SQLE,
WBSCR17]
[DEGS1, DHCR7, FDFT1,
FDPS, HMGCR, IDI1, LSS,
NSDHL, OXSM, PDSS1,
PLA2G6, SC4MOL, SCD,
ST8SIA6]
[CEBPA, DHCR7, FDPS,
HMGCR, LSS, NSDHL]
[AACS, ACAD11, ACOX2,
CEBPA, DEGS1, DHCR7,
FDFT1, FDPS, HMGCR,
IDI1, LSS, NSDHL, OXSM,
PDSS1, PLA2G6, PLCD1,
PRDX6, SC4MOL, SCD,
ST8SIA6]
[CEBPA, DHCR7, FDPS,
HMGCR, HPRT1, LSS,
NSDHL, SNCAIP]

GO
Regulation of
transmembrane transport

3.5 E-2

Calcium ion transport

3.6 E-2

Cellular calcium ion
homeostasis

4.3 E-2
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[BCL2, CACNG4, GNA11,
TRPV2]
[BCL2, LOC395914,
SLC24A2, TRPV2]
[AGTR1, BCL2,
LOC395914, SLC24A2]

Table 3-3 Continued
Cluster Annotat GO term (Biological
ion
process, level of 6 or 7)
or KEGG pathway
name
Regulation of membrane
potential
Positive regulation of cell
development
KEGG
Biosynthesis of
5
unsaturated fatty acid
(300
genes)

FDR pvalue
4.4 E-2
4.6 E-2

1.5 E-3

Endocytosis
2.9 E-2

6
(151
genes)

[ADAM22, BCL2, GNA11,
UGT8]
[BCL2, CDH4, DCT,
TRPV2]
[ELOVL5, FADS1, FADS2,
PTPLB]

[ACAP2, CHMP1B, EGFR,
KIT, LDLRAP1,
RCJMB04_3g13, SMAD7,
STAM]

GO
Fat cell differentiation
Regulation of
neurological system
process
Regulation of
transmission of nerve
impulse

7
(473
genes)

Genes

KEGG

2.1 E-3

[ARID5B, EIF2AK3,
LAMB3, SOD2, TCF7L2]

1.0 E-2

[ATAD1, EIF2AK3,
LAMA2, TCF7L2]

1.4 E-2

[ATAD1, EIF2AK3,
LAMA2, TCF7L2]

Multicellular organismal
signaling

3.2 E-2

Transmission of nerve
impulse

3.6 E-2

Oxidation-reduction
process
Cellular amino acid
metabolic process
Steroid biosynthesis

4.3 E-2
4.8 E-2

[ATAD1, CAMK4,
EIF2AK3, LAMA2,
TCF7L2]
[ATAD1, CAMK4,
EIF2AK3, LAMA2,
TCF7L2]
[NDUFB4, NDUFB8,
SOD2, TALDO1]
[BCKDHB, BHMT, MUT,
SOD2]
[DHCR24, HSD17B7, LIPA]

4.2 E-2
Oxidative
phosphorylation

5.0 E-2
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[ATP5G3, ATP5O,
ATP6V1C2, COX6C,
COX7A2L, NDUFA10,
NDUFA2, NDUFC2]

Table 3-3 Continued
Cluster

Annotat
ion
GO

GO term (Biological
process, level of 6 or 7)
or KEGG pathway
name
Negative regulation of
low-density lipoprotein
particle receptor
biosynthetic process
Myeloid cell
differentiation

8
(262
genes)

KEGG

Negative regulation of
macrophage derived
foam cell differentiation
Regulation of myeloid
cell differentiation
Lysine degradation

Rgulation of neuron
projection development
Negative regulation of
transferase activity
Peptidyl-tyrosine
phosphorylation
Peptidyl-tyrosine
modification
Negative regulation of
kinase activity
Regulation of neuron
differentiation
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FDR pvalue

Genes

2.8 E-2

[ADIPOQ, ITGAV]

3.0 E-2

[ADD1, ADIPOQ, CAMK4,
HMGB2, JAG1, LMO2,
NDFIP1, PRDX3, TESC]

3.3 E-2

[ADIPOQ, ITGAV]

3.7 E-2
5.0 E-2

4.2 E-2
4.5 E-2
4.7 E-2
4.7 E-2
4.9 E-2
4.9 E-2

[ADIPOQ, HMGB2, JAG1,
LMO2, NDFIP1, TESC]
[ASH1L, PLOD2,
SUV420H1]
[CCDC88A, GOLGA2,
LYN, PSEN1, PTEN]
[LYN, PRDX3, PSEN1,
PTEN]
[IL31RA, JAK1, LYN,
PDGFRA, PSEN1]
[IL31RA, JAK1, LYN,
PDGFRA, PSEN1]
[LYN, PRDX3, PSEN1,
PTEN]
[BMP6, CCDC88A,
CDK5RAP2, GOLGA2,
LYN, PSEN1, PTEN]

Table 3-4 Correlation of Adipocyte size with 53 common genes identified by three
pairwise contrasts.
Gene
Correlation
Signif Prob
PQLC3
-0.95
7.31E-08
SQLE
0.94
1.34E-07
DCT
-0.94
2.19E-07
SYT15
-0.91
3.27E-06
TMEM164
0.89
8.00E-06
LOC100859544
-0.89
1.03E-05
FAS
-0.88
1.24E-05
RDM1
-0.88
1.39E-05
CEP170
0.88
1.48E-05
USPL1
-0.88
1.75E-05
WIF1
-0.86
4.75E-05
IFI27L2
-0.86
4.86E-05
LOC420414
-0.84
7.54E-05
GNL3
-0.84
1.03E-04
CXCR4
0.82
1.75E-04
RASD1
0.81
2.33E-04
LACE1
0.78
6.49E-04
MTMR2
0.71
2.98E-03
NHP2L1
0.70
3.78E-03
MPZL1
0.65
8.60E-03
PON2
0.61
1.58E-02
HEY1
-0.59
1.97E-02
NMRAL1
0.59
2.00E-02
VLDLR
0.58
2.41E-02
DCAF6
-0.58
2.41E-02
ALDH6A1
-0.57
2.54E-02
ERGIC1
-0.52
4.86E-02
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Table 3-5 Fold change of adipose tissue metabolites in pairwise comparisons of three
strains (broiler, Leghorn, and Fayoumi)
FayoumiMetabolites
Broiler
ox._Glutahione_or_DG
5.28***
Threonine_(POS)
4.11***
Pantothenate
1.65***
Oxidized_Glutathione_(GSSG) 2.49**
Pyruvate
1.43***
1-Methyladenosine
5.76***
Pentose_Phosphate
3.73***
Ornithine
2.65***
IMP
0.89
Nicotinamide_Ribotide
1.99**
Aspartate
1.73**
Reduced_Glutathione_(GSH)
1.88**
Ceramide
1.93
Lysine-(67)
2.15***
Proline
1.90**
Carnitine
3.44**
Lysine-(84)
1.77**
Valine
1.62**
Acetylcarnitine_DL
3.57***

LeghornBroiler
0.87
1.46***
0.63***
1.20
0.74
3.21***
2.09***
1.54
0.53***
1.34**
1.23
1.38***
1.42
1.62***
1.45**
2.69***
1.41***
1.33***
2.94***

LeghornFayoumi
0.16**
0.36***
0.38***
0.48
0.52***
0.55
0.56
0.58
0.60
0.67
0.71**
0.73
0.74
0.75
0.76
0.78
0.80
0.82
0.82

Deoxyguanosine
Guanosine
5prime-Methylthioadenosine
Glycerophosphocholine
Taurine
Guanine
Creatinine
Riboflavin
N-Acetylglucosamine-1Phosphate
Serine
Xanthine_(POS)
Lactate
Malate
Cytidine
Nicotinamide
Asparagine
Adenosine

2.03***
3.17***
2.16***
2.48***
1.48***
2.35***
1.77***
1.40

1.71**
3.03***
2.13**
2.53***
1.59**
2.62***
2.03**
1.65**

0.84
0.95
0.98
1.02
1.08
1.11
1.14
1.17

1.73***
1.32***
1.59**
0.78**
1.30
1.44
1.07
0.99
2.19**

2.10**
1.64**
2.04***
1.00
1.81***
2.01***
1.54**
1.55***
3.47***

1.22
1.25
1.29
1.29
1.39
1.39
1.43
1.56***
1.59
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Table 3-5 Continued
Metabolites
Cytosine
Citrulline
Glycerol-3-Phosphate
deoxyribose
Ethanolamine_or_Urea
Imidazoleacetic_Acid
1-Methylhistidine
Hypoxanthine_(NEG)
3-Phosphoglycerate
NADPH
Phosphoenolpyruvate

FayoumiBroiler
2.76**
2.06***
0.64
1.97**
1.91**
2.02
1.13
1.33
0.96
0.31***
1.39

** p < 0.05, *** p < 0.01, **** p < 0.001
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LeghornBroiler
4.39***
3.29***
1.10
3.61***
4.07***
4.33***
2.48***
3.13**
3.46***
1.24
7.42***

LeghornFayoumi
1.59
1.59
1.71
1.83
2.13**
2.15
2.19***
2.36**
3.61**
4.02**
5.33

Figure 3-1. A. Histology of abdominal adipose tissue from broiler, Fayoumi and
Leghorn. Scale bar: 500 μm. B. Adipocyte area was measured using ImageJ
software. Mean adipocyte area in broiler, Fayoumi and Leghorn (n = 7/group). C.
the distribution of adipocyte area. When letters above bars differ, means significantly
differ by p<0.05.
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Figure 3-2. QPCR results for selected genes in chickens. Results are expressed as
fold change determined using the ΔΔCt method. Blue: broiler, red: Fayoumi, green:
Leghorn. *p<0.05, **p<0.01. ***p<0.001
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Figure 3-3. Venn diagram of overlapping and unique effects of Leghorn and
Fayoumi vs. broiler (a) A total of 2361 genes were differentially expressed (FDR
adjusted pvalue <0.05) between one or more pairwise treatment comparisons; (b) A total
of 2212 genes with absolute fold change ≥1.5 among the differentially expressed genes.

96

Figure 3-4. Cluster analysis of differentially expressed genes. The 2361 genes
differentially expressed in one or both inbred chickens vs. broilers were subjected to
hierarchical clustering to visualize similarities and differences between breeds. (a).
Hierarchical cluster analysis of the 2361 genes (FDR adjusted pvalue <0.05) that were
differentially expressed between Leghorn vs. broiler and/or Fayoumi vs. broilers. (b)
Expression profiles of eight clusters extracted by hierarchical cluster. Sample ID number
on the X-axis corresponds to treatment group: sample 1-6, broiler; 7-11, Fayoumi; 12-17,
Leghorn. Y-axis represents relative gene expression value.
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A
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B

C

Figure 3-5 KEGG pathways analysis of genes differentially expressed genes. Genes were matched to KEGG pathway membership
using ClueGO. (A) Leghorn vs. broiler. (B) Fayoumi vs. broiler (C) Leghorn vs. Fayoumi. The percentage and #genes/term indicates
the percentage and number of the genes in the pathway that are contained in the set of genes differentially expressed in different
breeds of chicken. • p < 0.1 * p < 0.05 **, p < 0.01, based on Benjamini-corrected p-value
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Figure 3-6 Shared traits of naturally lean chickens.
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CHAPTER IV
GENE EXPRESSION SIMILARITIES BETWEEN FASTED
AND LEAN PHYSIOLOGIES IN DOMESTIC CHICKENS
This manuscript will be submitted to Poultry Science with the following author list:
Bo Ji, Ben Ernest, Arnold M. Saxton, Susan J. Lamont, and Brynn H. Voy

Introduction
Obesity in humans may be attributable in part to decreased oxidation of fatty
acids in skeletal muscle, the primary contributor to whole body fatty acid oxidation.
Fatty acid oxidation is impaired systemically, and specifically in skeletal muscle, in obese
vs. normal weight patients [208-210]. Obesity is associated with a variety of metabolic
changes, however, it is difficult to determine which is the cause and which is the
consequence of the obese state. Nonetheless, some studies suggest that impaired fatty
acid oxidation is a primary defect that contributes to the development of obesity. Normal
weight subjects with a family history of obesity were shown to have lower rates of fatty
acid oxidation than individuals with no family history [211]. Further, normal weight
children with an obese parent also exhibit reduced fatty acid oxidation in muscle [212],
suggesting a genetic component to fatty acid oxidation that is inked to leanness.
Little is known about the role of fatty acid oxidation in the control of leanness in
chickens. In our previous studies (Chapters 2 and 3), we found gene expression profiles
indicative of increased fatty acid oxidation in adipose tissue of fasted broilers vs. fed and
in genetically lean Leghorn and Fayoumi lines compared to broilers. We therefore
reasoned that fasting and genetic leanness may share common features in terms of
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adipose tissue metabolism, including increased fatty acid oxidation. To explore this
possibility, we conducted a combined analysis of gene expression profiles from the
fasting and insulin-neutralization study and from the study of broilers, Leghorn and
Fayoumi. The two studies were performed in different countries and with differences in
husbandry, age of animals and other unknown confounds. We also compared the effects
of fasting and leanness on adipose metabolism signalling pathways using Western blot
analyses and on the fatty acid composition of adipose tissue using GC-MS. Part of the
Western blot results described in this chapter were previously published in [68].

Methods
Quantification of fatty acids with gas chromatography/mass spectrometer
(GC/MS)
Fatty acids samples were prepared for GC-MS analysis following the steps of
lipid extraction, triglyceride hydrolyzation, esterification and methylation of fatty acids
according to the methods described [208-210]. Nonadecanoic acid was used as an
internal control. Approximately 10-50 mg adipose tissue was homogenized using 2:1
chloroform:methanol. Lipids were extracted in the organic phase by centration. Lipids
were hydrolyzed using 0.3 M KOH in methanol and incubated at 80°C for 60 minutes.
Boron trifluoride (BF3, 12-15%) in methanol was used as an acid catalyst for
esterification and transesterification. In esterification, a methyl group from methanol is
added to the carboxyl group of free fatty acids at 90°C for 90 minutes. Fatty acids were
reconstituted in hexane for GC-MS analysis. The fatty acid methyl ester was analyzed
using a gas chromatography system, Agilent 6890 GC G2579A system (Agilent)
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equipped with an OMEGAWAX 250 capillary column (Supelco) and a flame ionization
detector. An Agilent 5973 mass selective detector was used to identify target peaks.
Western blotting
Western blotting was used to determine the effects of fasting and insulin
neutralization

on insulin and stress signaling by investigating the protein levels of

phosphorylated and total AKT, ERK, AMPK, S6K, mTOR, p38 (Cell Signaling). Protein
lysates was prepared by tissue extraction buffer (Invitrogen) supplemented with protease
and phosphatase inhibitor (Roche). Proteins were detected using ECL Plus
chemiluminescent substrate (gelifesciences.com) and intensity of signals following
hybridization was measured using a chemiluminescent detector (Versadoc; bio-rad.com).
Statistical analysis
Statistical analysis of the microarray data was performed using R 2.13. Data
normalization and processing was performed as described previously [184]. Statistical
significance of gene expression differences were analyzed by two-way ANOVA
(treatment (T) and country (C) factors) and empirical bayes using the limma package.
Differential expression was defined based on false discovery rate (FDR) adjusted p-value
<0.05. Venn diagrams of differentially expressed genes were plotted to visualize the
number of differentially expressed genes for each factor and interaction of factors.
Hierarchical clustering of significant genes was performed using the hclust function and a
hierarchical clustering heatmap was created using heatmap.2 in the gplots package.
The model (Equation 1) was based on defining treatment level 1 as fasted
chickens (France) and lean Leghorn (US), and treatment level 2 was broilers from both
countries. Country factor represent the variations associated with geographical and
husbandry effects.

102

Yij=μ+Ti +Cj+T*Cij

(1)

The difference between birds for each fatty acid was evaluated by analysis of
variance (ANOVA) and post hoc Tukey test for multiple comparisons in SAS (SAS
Institute, Cary, NC). The correlation coefficients of phenotypic traits and gene expression
were based on Pearson correlation.

Results
Mega-analysis of Affymetrix data from different studies
Two-way ANOVA model identified that 1587 genes were differentially expressed
in terms of treatment, and 1919 genes in terms of country factor, and 390 genes affected
by the interaction of treatment and country based on an FDR adjusted p-value < 0.05. The
genes of interest are 1049 genes (954 genes of them with fold change> 1.5) that were
only altered by treatment, but not by country and/ or interaction of treatment and country
(Figure 1A).
Hierarchical cluster analysis was employed based on 1049 genes that were only
significantly altered by treatment factor. As shown in Figure 1B, broilers fed ad libitum
were clustered with broilers, whereas fasted birds were clustered together with lean
Leghorn chickens. Five clusters representing different patterns were identified in terms of
gene expression denoted by the color bar (Figure 1B). The genes in cluster 1 (493 genes)
were of interest because they showed very consistent low expression in lean and fasted
chickens, but high expression in broilers. These genes were submitted to DAVID Gene
Ontology analysis, which provides the biological interpretation of the clusters and
identifies significantly over-represented GO terms and pathways (Table 1).
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Effects of fasting and insulin neutralization on phosphorylation of Akt,
MAPKs ERK1/2, mTOR, S6K, AMPK, and P38MAPK in chicken adipose
tissue
The effects of fasting and insulin neutralization on phosphorylation of Akt,
AMPK, MAPKs ERK1/2, mTOR, S6K and P38 insulin signaling pathways were
evaluated in chicken adipose tissue (Figure 4-2). Our results suggested that
phosphorylation of Akt, ERK1/2, S6K were decreased by fasting and insulinneutralization in chickens. However, there was no significant effect of fasting and
insulin-neutralization on phosphorylated level of mTOR and AMPK. Interestingly,
fasting significantly increased MAPK P38 phosphorylation in chicken adipose tissue.
Phosphorylation of Akt, MAPKs ERK1/2, S6K, AMPK, and P38MAPK in
adipose tissue of lean and broilers
Our data suggested that the phosphorylated levels of Akt, MAPKs ERK1/2, S6K
and P38MAPK were similar between Leghorn, Fayoumi and broilers. Nevertheless,
phosphorylated level of AMPK was higher in Fayoumi vs. broilers (Figure 4-3).
Effect of fasting and insulin neutralization on compositions of fatty acids
Compositions of most fatty acids were not altered by fasting and insulin
neutralization, except for cis-vaccenic (18:1( n-7)) and linoleic acid (18:2 (n-6)), which
were statistically significant lower in fasted vs. fed chickens (p<0.05). However, absolute
concentrations of fatty acids are consistently lower in fasted chickens than in fed
chickens (data not shown). There was no significant difference of fatty acid compositions
in insulin neutralized chickens compared to ad libitum fed chickens.
Compositions of fatty acids in Leghorn, Fayoumi and broilers
Oleic acid (18:1 (n-9)), a monounsaturated fatty acid, is the most abundant fatty
acid in chicken adipose tissue, accounting for about 40% of total fatty acids. The
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abundance of oleic acid was significantly lower in Leghorn than broilers (p<0.05).
Compositions of some other fatty acids, including myristic acid (14:0), palmitic acid
(16:0), stearic acid (18:0), and linoleic acid (18:2 (n-6)), were significantly higher in
Leghorn vs. broilers and Fayoumi (p<0.05). Consequently, the ratios of saturated fatty
acids to unsaturated fatty acids were significantly higher in Leghorn vs. broilers and
Fayoumi (p<0.05).

Interestingly, docosahexaenoic acid (DHA, 22:6 (n-3)) was

significantly higher (p<0.05) in Leghorn vs. Fayoumi, as was the ratio of EPA and DHA
to AA, which is the ratio of n-3 to n-6. In contrast, Fayoumi had similar compositions of
fatty acids as broilers, except that Fayoumi had the highest abundance of oleic acid, and
the highest ratio of n-3 to n-6 among the three lines of chickens.
Correlation of physiological responses and gene expression
The correlations of physiological responses to fasting and insulin neutralization
and gene expression were investigated. Variables with correlation coefficients higher
than 0.7 (p<0.001) were considered as strongly correlated. Plasma triodothyronine (T3)
was highly correlated with expressions of a large number of genes (901 genes). Plasma
glucose was highly correlated with 140 genes. Plasma glucagon and NEFA were highly
correlated with 143 genes and 525 genes, respectively. Some of the genes were both
highly correlated with plasma levels of hormones and metabolites (Figure 4-4).
Interestingly, eight unique genes that are only highly correlated with glucagon include
GCG, ST13, and TCP11L2, which were also identified as uniquely differentially
expressed in insulin neutralized chickens.

Discussion
We sought to identify similarities in gene expression signatures between leanness
and feed restriction by integrating the array data generated from previous studies.
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However, the true effect of the treatment was confounded by geographical and husbandry
factors associated with these distinct studies. To account for these confounding
experimental factors, we first developed a linear model to identify the effect of the
confounding factor and its interactive effect with treatment, then excluded the genes that
were affected by the confounding factor and its interaction with treatment. The genes that
were only affected by treatment factor were submitted for hierarchical clustering and
Gene Ontology analysis. Two-way ANOVA model identified the similarities between
fasting broiler and naturally lean chickens. Cluster 1 contained genes with lower
abundance in Leghorn and fasted chickens vs. broilers were significantly enriched in
fatty acid biosynthetic and metabololic process, steroid and carboxylic acid biosynthetic
process (Benjamini adj. pvalue<0.05). Cluster 2 and 3 consisted of genes with higher
expression in lean and fasted chickens compared to broilers. These clusters were enriched
in genes involved in immune responses and in fatty acid oxidation, including PDK3,
PDK4, ACACB, and CPT1A. This method increased power and accuracy to detect
differentially expressed genes in fasted broilers and lean chickens compared to fed
broilers, regardless of breeds, geographical and husbandry factors. Furthermore, it
identified the similarities of fasted broilers and naturally lean Leghorn lying in the
categories characterized by decreased fatty acid biosynthesis and increased fatty acid
oxidation.
Chickens are considered to be refractory to insulin. Chicken muscle showed
insulin resistance, but only in the early steps of insulin signaling [58, 67]. Moreover,
genetically fat and lean line chickens showed apparent difference in insulin signaling in
response to feeding, prolonged fasting and refeeding. Fat line chickens exhibited higher

106

insulin sensitivity in liver than lean line chickens in terms of early steps (IRß, IRS-1, Shc
and PI3K) of insulin signaling cascade, which would account for increased liver
lipogenesis in fat line chicken [64]. Nevertheless, little difference was observed in leg
muscle of fat line chickens regarding the early steps of insulin signaling in response to
nutritional status, which may be due to consistent refractory to insulin in muscles [64].
However, little is known about chicken adipose tissue. In this study, we assessed
phosphorylated levels of insulin signalling cascades in chickens from both studies to
characterize the effects of fasting and insulin on signalling pathways, and insulin
signalling cascades in different breeds of chickens.
In terms of the effects of fasting on insulin signaling pathways, the genes up or
down stream of AKT, ERK and mTOR signaling pathways were significantly
differentially expressed in fasted chickens, such as DUSP5, MYC, MAP3K5.
Consistently, decreased phosphorylated levels of AKT, ERK, mTOR and p70S6K were
observed in fasted chickens. AMPK, which is considered as energy sensor, is activated in
response to nutrient deficiency or stress to support cellular metabolism and maintain the
ATP cellular level. However, the activation of AMPK by 5-hour fasting was not
significant (Fig. 3). For the stress signaling, TLR4 and TNFR6, which are up-stream of
JNK signaling pathways were up-regulated. It is consistent with the activation of p38 and
indicated the promotion of inflammation in adipose tissue through the released fatty acids
by fasting. As described in Chapter 3, we found that Expression of PRKAA1 and
PRKAB2, which encode catalytic and regulatory subunits of AMPK, were up-regulated
(21- and 2- fold, respectively) in Fayoumi vs. broiler adipose tissue. Correspondingly,
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phosphorylated level of AMPK was higher in Fayoumi than broilers, whereas the
difference was not observed in Leghorn chickens.
AMPK plays a major role in ACC and MCD regulation by phosphorylating and
inactivating ACC activity, but activating MCD activity, which favors fatty acid oxidation
[206]. Together with increased expression of genes involved in fatty acid oxidation,
activation AMPK further implicated favored fatty acid oxidation in lean chickens.
Additionally, PDK4 expression was shown to be induced by activation of p38MAPK in
mouse white adipose tissue [169], which was also observed in adipose tissue of fasted
and lean chickens.
Like humans, but unlike rodents, oleic acid is the most abundant fatty acid in
adipose tissue of chickens[211]. Linoleic acid (18:2) is an essential fatty acid not
synthesized in the body of animals, which is derived from diet. Linoleic acid was higher
in Leghorn, which only indicated the differences in their feed uptake. Leghorn had less
unsaturated fatty acids and more saturated fatty acids than broilers, which is different
from previous studies on mice. Obese mice had significant increases in saturated fatty
acids, and a significantly decrease in unsaturated fatty acids. The opposite result in lean
chicken is propably due to the egg-laying feature of Leghorn, which have their specific
features of lipid homeostasis and fatty acids transfer to maintain follicular cells and form
the yolk. Another reason for increased saturated fatty acids may be due to their different
expression of fatty acid elongase. Fatty acid elongase 6 (ELOVL6) is the rate-limiting
elongase related to de novo lipogenesis. Pigs carrying the allele associated with a
decrease in ELOVL6 gene expression had increased C16:0 and C16:1 (n-7) fatty acid
content and a decrease of elongation activity ratios in muscle and backfat [212]. This may
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explain higher composition of palmitic acid in Leghorn than broilers, since ELOVL6 was
up-regulated in Leghorn.
Leghorn contained higher percentage of DHA, which is beneficial to humans by
providing natural source of n-3 PUFA and also indicated the higher anti-inflammatory
modulations in lean chickens. Dietary intake of n-3 PUFA reduced the incidence of
myocardial infarction and chronic inflammatory or autoimmune disorders[213]. EPA
and DHA reduce adiposity in humans and rodents either by increasing fatty acid
oxidation in liver and adipose tissue or by inhibiting hepatic lipogenesis [214]. EPA and
DHA also activates AMPK in adipose tissue and cultured adipocytes. Increased ratio of
n-3 PUFA to n-6 PUFA in Fayoumi may be the reason for increased phosphorylated
levels of AMPK in adipose tissue of Fayoumi chickens compared to broilers. DHA is
synthesized through peroxisomal beta oxidation by shortening C24:6 n-3 [52]. An
increase in DHA also implicated increased occurance of fatty acid oxidaiton in lean
chickens compared to broilers.
Collectively, our results provided further evidence that the leanness of Leghorn
and Fayoumi are associated with increased fatty acid oxidation in adipose tissue. Our
results also provide an important basis to understand the potential connections between
fasting, leanness and adipose inflammation, so that we can go further to investigate the
relationship between nutritional status, fat deposition and the innate immune system in
poultry.

109

A

B

Figure 4-1. A. Venn diagram of differential expressed genes (adjusted
pvalue<0.05) in terms of treatment factor, country factor and their
interaction. B. Hierarchical cluster analysis of the 1049 genes (FDR
adjusted pvalue <0.05) that were differentially expressed in terms of
treatment. The colour bar denotes five clusters extracted by
hierarchical cluster.
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Figure 4-2. Western blots revealed increased abundance of phosphorylated
p38MAPK and decreased phosphorylated ERK1/2 and S6K
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Figure 4-3. Western blots revealed increased abundance of phosphorylated
p38MAPK in Fayoumi chickens
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Table 4-1. Fatty acids composition in adipose tissue of broiler, Leghorn and
Fayoumi
Broiler
Leghorn
Fayoumi

myristic acid

14:00

0.0035a

0.0045b

0.0031a

myristoleic acid

14:1 (n-5)

0.0005a

0.0003a

0.0003a

palmitic acid

16:00

0.1672a

0.2168b

0.1445a

cis-7-hexadecenoic acid

16:1 (n-9)

0.0032ab

0.0026a

0.0029a

palmitoleic acid

16:1 (n-7)

0.0374ab

0.0213a

0.0245a

stearic acid

18:00

0.0392a

0.0669b

0.0429ab

oleic acid

18:1 (n-9)

0.4933b

0.3644a

0.5566c

cis-11-octadecenoic acid
(cis-vaccenic)
linoleic acid

18:1 (n-7)

0.0079a

0.0076a

0.0089a

18:2 (n-6)

0.2426a

0.3113b

0.2124a

cis-5,8,11,14,17Eicosapentaenoic acid
(EPA)
arachidonic acid (AA)

20:5 (n-3)

0.0048ab

0.0040b

0.0038a

20:4 (n-6)

0.0002ab

0.0001a

0.0001a

all-cis-4,7,10,13,16,19Docosahexaenoic acid
(DHA)

22:6 (n-3)

0.0002a

0.0003b

0.0002a

16:0/16:1

4.1214a

9.0468b

5.2659a

18:0/(18:1+18:2) 0.0527a

0.0979b

0.0551a

45.5205b

60.4438c

EPA+DHA/AA
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27.9042a

Table 4- 2. Fatty acids composition in adipose tissue of broiler ad libitum, fasted for
5 hours and insulin-neutralized
Fasting
Fed
Insu-Neu
myristic acid
myristoleic acid

14:00
14:1 (n-5)

0.0022
0.0002

0.0021
0.0002

0.0023
0.0003

palmitic acid
cis-7-hexadecenoic acid

16:00
16:1 (n-9)

0.0704
0.0033

0.0640
0.0027

0.0687
0.0031

palmitoleic acid

16:1 (n-7)

0.0218

0.0236

0.0213

stearic acid
oleic acid

18:00
18:1 (n-9)

0.0351
0.6708

0.0320
0.6305

0.0335
0.6187

cis-11-octadecenoic acid
(cis-vaccenic)
linoleic acid

18:1 (n-7)

0.0093a

0.0204a

0.0117a

18:2 (n-6)

0.1838a

0.2213a

0.2378a

cis-5,8,11,14,17Eicosapentaenoic acid
(EPA)
arachidonic acid (AHA)

20:5 (n-3)

0.0026

0.0026

0.0022

20:4 (n-6)

0.0002

0.0002

0.0002

all-cis-4,7,10,13,16,19Docosahexaenoic acid
(DHA)

22:6 (n-3)

0.000278ab

0.000344a

0.000265b

2.4349
0.0491
12.6882

2.8144
0.0532
15.9688

16:0/16:1
2.8091
18:0/(18:1+18:2) 0.0516
EPA+DHA/AA
16.1839
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Figure 4-4. Four-way venn diagram of overlapping and unique genes highly
correlated with plasma glucose, glucagon, NEFA, and T3.
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CHAPTER V
CONCLUSIONS AND FUTURE PERSPECTIVES
We used an approach that couples comprehensive transcriptomic and
metabolomic methods with system and cellular physiology to identify the mechanisms
that regulate fat deposition in domestic chickens. The results are summarized as below:
A short term (5-hour) fast impacted expression of genes in a broad selection of
pathways related to metabolism, signaling and adipogenesis. Fasting up-regulated ratelimiting genes in both the mitochondrial and peroxisomal pathways of beta-oxidation.
Short term fasting suppressed adipogenesis; expression of key genes in multiple steps of
adipogenesis, including lineage commitment from mesenchymal stem cells, were
significantly down-regulated in fasted vs. fed adipose tissue. Microarray analysis of
Fayoumi, Leghorn and broiler adipose tissue revealed that genetic leanness shared
molecular signatures with the effects of fasting. Fatty acids components were
significantly different between lean chickens and broilers. Chicken adipose tissue is
refractory to insulin. Collectively, these data suggest that leanness in chickens is
associated with increased fatty acid metabolism toward oxidation, rather than storage. It
is surprising because white adipose tissue is not traditionally considered a site of
significant fatty acid oxidation, which is more for muscle. Previous studies focused on
fatty acid oxidation in liver and muscle, and ignored the occurrence of fatty acid
oxidation in adipose tissue. Our study, for the first time, comprehensively investigated
the association of adipose metabolic and physiological responses with gene expression in
avian. Our study also identified the unique features of adipose metabolism of naturally
lean chickens (layer and meat type) compared to broilers. These results also highlight
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chicken as a useful model organism in which to study the dynamic relationship between
food intake, metabolism, and adipose tissue biology.
Based on the findings of our studies, future studies will focus on reduction of fat
deposition by regulation of lipolysis and fatty acid oxidation and the mechanism behind
the effect of lipolysis and fatty acid oxidation. For example, does lipolysis induce
activation of macrophages? Does overexpression of PDK4 in adipose tissue lead to
increased fatty acid oxidation and reduced fatness? A tissue specific overexpression or
knockout of PDK4 experiment is helpful to answer this question. Furthermore, how do
fatty acid components dynamically change with lipolysis and fatty acid oxidation? It
would also need to be determined if oxidative stress is associated with increased fatty
acid oxidation.
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